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1. Introduction 
Bioanalysis, a fundamental research area of analytical chemistry, concerns the identification 
and quantification of molecules in biological systems. One of its major interests is human 
health, which focuses on detection of biomolecules that exist, for example, as a result of a 
certain infectious disease. Antibodies, for instance, can be detected in body fluid, indicating 
the presence of an infection. The early detection of such biomolecules would allow an early 
treatment of the disease successfully via antibiotic; and this would assist further in 
prohibiting the transition of the infectious disease as well as would reduce the risk of more 
advanced sever health problems. Therefore, a simple, rapid, and sensitive test is needed to 
detect and quantify the infecting agent. Besides the test should be cost effective and easy to 
interpret.  
Ligand-binding immunoassay is the most commonly used analytical procedure to detect 
antibodies in body fluids. This is due to its high sensitivity, besides its high specificity. 
In the presented thesis, a Borrelia infection (one of the most common infectious diseases in 
North America and Europe) was taken as a model to develop novel ligand-binding 
immunoassay platforms for rapid point of care testing.  
 
1.1 Immunoassays 
Immunoassay is a widely used laboratory and on-site test; it enables a high specific and 
sensitive detection of analytes, ranging from small molecules (1) to intact cells (2). The main 
concept of the assay performance is based on a high specific interaction between antibody, 
the key component, and antigen. The antigen or the antibody is used to recognize the immune 
agent (analyte); following, detection of the produced antibody-antigen complex (immune 
complex) can be easily conducted. In effect, detection of the infectious disease is 
accomplished (Figure 1). 
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Figure 1 A scheme illustrates the employment of immunoassays in detection of infectious 
diseases. Antibodies are used to recognize the antigen (infecting agent) in sample. A label 
can then be added to monitor the interaction.   
 
Since the first immunoassay that was developed by Yalow and Berson for insulin 
determination in 1960 (3), this type of antigen-antibody interaction dependent techniques 
have been developed and found their applications in diverse areas; it has been applied in 
determination of chemical molecules, biomolecules and even whole cells. For example, 
determination of toxins (4), cancer biomarkers (5), environmental contaminants (6), whole 
cells (7), proteins concentration, as well as determination of small molecules in clinical 
samples, such as body fluids, could be applicable. Yalow and Berson developed a highly 
sensitive assay based on a radioisotope labeled antigen or antibody in a competitive analysis 
way, radioimmunoassay technique (RIA).  
RIA was extensively used subsequently in diverse areas of biomedical and clinical diagnosis 
such as measurement of pepsinogen in porcine blood samples (8), and determination of 
vasopressin in plasma (9). Yet, RIA possesses some drawbacks that limited the further use of 
such approach. Namely, the special and long arrangement for requisition and handling of the 
radioactive materials, the short living nature of the radioisotope label, which causes 
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subsequently shortening the shelf-life of the labeled antibody or antigen, the hazard health the 
radioisotopes constitutes, and the waste disposal problems. Besides, RIA is not adequate for 
the direct determination of samples, since the decrease in detected signal could be arisen by 
other factors rather than a specific antibody-antigen interaction (10).  
As alternative, immunoassays have been evolved to using enzymes for detection instead of 
radioisotopes. Enzymes have the ability to undergo chemical reactions, providing a sensitive 
and a clear detection. A single copy of an enzyme can generate many product molecules, 
which in turn would decrease the detection limit of the measurements by amplifying the 
signal. An enzyme that is coupled to either the antigen or the antibody reacts with a substrate 
producing a physically or chemically detectable product, mostly a colored precipitate. The 
colored products can then be easily measured using a spectrophotometer. Electrochemical 
detection could be also employed to detect the enzyme reaction (detection of electrons 
movement between an electrode and a substrate is mainly possible after an enzymatic 
reaction) (11).  
The quantitative measurements of immunoglobulin G (IgG) antibodies in rabbit serum using 
alkaline phosphatase enzyme (12) and the quantitative determination of human chorionic 
gonadotropin in urine using horseradish peroxidase enzyme (HRP) (13) are considered the 
pioneer studies in using enzymes for detection in immunoassays.  
HRP has become the most common used enzyme in immunoassays since then; the reason is 
due to that, HRP has the ability to oxidize numerous of chromogenic substrates, e.g. 3,3',5,5'-
tetramethylbenzidine (TMB), 3,3',4,4'-biphenyltetramine, and 2,2'-azino-bis(3-
ethylbenzothiazoline-6-sulphonic acid) (ABTS). These chromogenic substrates convert in 
turn into colored products, which can be easily monitored, in the presence of an oxidizing 
agent such as hydrogen peroxide (14). TMB substrate can be oxidized by HRP to form a 
cation radical intermediate, which in turn could be combined to form a charge-transfer 
complex. The complex can be seen easily at acidic pH as a blue precipitate; besides it can be 
measured at 650 nm (14). The cation intermediate can also further oxidized to form a yellow 
colored diimine derivative that can be measured at 450 nm (Figure 2). 
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Figure 2 Oxidation of TMB using HRP enzyme in presence of oxidizing agent (H2O2). 
Oxidation reaction results in a charge-transfer complex, which can be seen at acidic pH as a 
blue precipitate. The maximum absorbance of the blue precipitate can be measured at 650 
nm. Further oxidation of TMB would result in a yellow diimine derivative that has maximum 
absorbance at 450 nm.  
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Although enzymes enhanced the signal and decreased the limit of detection, other studies 
have been conducted to increase the immunoassay sensitivity even more.  
Woodhead reported more sensitive test in 1985. The test is based on using 
chemiluminescence, a label capable of emitting light after a chemical reaction (15). 
Woodhead developed an immunoassay based on using acridinium ester as labels; it has the 
advantage of producing light under mild conditions with no requirements for a catalyst.  The 
reaction takes place under aqueous conditions at basic pH in presence of hydrogen peroxide. 
As a result an excited product is formed, which emits light after it relaxes to its ground state 
(Figure 3). The photons can be emitted as a result of relaxation of an exited product to its 
ground state after an exoergic reaction; the intensity of the emitted light is related to the 
concentration of the tested sample.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3 Mechanism of chemiluminescence reaction of acridinium ester. An excited product 
is formed in presence of oxidizing agent, which emits light after it relaxes to its ground state. 
 
Furthermore, diverse labels have been reported for immune complex detection; all have a 
main concern of enhancing the assay sensitivity. For example, nanoparticles, dyes, and 
fluorogenic reporters have been used as labels for detection. 
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For many years, immunoassays have been performed on a fixed platform, like microtiter 
plate, where the protein probe is fixed on a solid support. However, the assay possesses the 
disadvantage of that large volume of the sample is needed. Alternatively, microfluidics 
technique was evolved; a technique that manipulate and process the sample in very small 
amounts (10
-9
 – 10-18 L); the sample in a fluid moves freely in channels with diameter of ten 
to hundreds micrometers (16). Microfluidic immunoassays have a distinct characteristic of 
the diversity of designs and fabrications, which enable the analysis of different biomolecules. 
In addition, this type of microfluidic system characterized by the short analysis time and the 
low cost because of the low volume of reagents. As a disadvantage, the sensitivity is not 
enough in many applications. Nevertheless, many strategies based on microfluidic technique 
have been developed to amplify the test signal (17). More about design and fabrication of 
microfluidic techniques and its application can be found in this review (18).  
Another platform was also employed in immunoassay, which bring the chromatographic 
technique and immune chemical reaction together, is immunochromatographic assay. It is 
simple, cheap and suitable for on-site detection (19). Considering the need to obtain a simple, 
cheap and sensitive test, many other platforms have been also developed. For example, flow 
cytometric immunoassays (20), electrochemical immunoassays (21) and nanoparticle-based 
immunoassays (22).   
 
1.2 Classification of immunoassays 
As mentioned above, antigen or antibody in immunoassay is used to catch the immune agent 
(analyte) from the sample. Based on whether the bound analyte and unbound analyte are 
separated by a washing step or not, immunoassays can be classified into homogeneous or 
heterogeneous (23). Heterogeneous immunoassay is considered when the antigen or the 
antibody is immobilized on a solid surface; then loading of the other immune agent 
containing solution comes afterwards. An immune complex produced as a result, which can 
be detected using a labeled protein. The unbound proteins should be washed away before the 
detection step. The signal produced by the labeled protein is related in this case to the bound 
immune agent (24). Considering the detection of antibodies in sample, immunoassay is 
homogeneous when the antigen, the target antibody, and a well-controlled concentration of 
the labeled antigen are mixed in one solution. The antigen competes with the labeled antigen 
to antibody binding sites. A signal is generated due to a change in marker‘s activity when 
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coupled. Unlike the heterogeneous, there is no separation of unbound antigen or labeled 
antigen to get accurate signal (25). Figure 4 shows the difference between a homogeneous 
and a heterogeneous immunoassay. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 An illustration of the difference between heterogeneous and homogeneous 
immunoassays. In contrast to homogeneous assay, a washing step is needed in the 
heterogeneous assay in order to separate the bound and unbound analyte. 
 
Immunoassay can be designed in either competitive or noncompetitive manner. In 
competitive immunoassays an immobilized antibody has a limited binding sites; an antigen 
and a labeled antigen competes to those limited sites. The antigen can displace the labeled 
antigen on the antibody sites, as a result the higher the antigen concentration in the sample is, 
the lower the labeled antigen bind to the antibody and the lower the detected signal is (26). 
The unbound antigen and unbound labeled antigen can be easily washed, and bound labeled 
antigen concentration can be then detected. Competitive immunoassay is mostly used in 
determination of small molecules such as drugs.  
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In noncompetitive immunoassays, either antibody or antigen with high quantity is 
immobilized on a solid surface. Following, analyte is applied to the surface, and finally a 
secondary labeled antibody is loaded, which can be easily monitored (27). One common 
platform of noncompetitive immunoassays is sandwich enzyme-linked immunosorbent assay 
(ELISA), in which, a primary antibody is immobilized and a labeled antibody can bind to an 
antigen, which is previously bound to the primary antibody; in sandwich ELISA the antigen 
should have two epitopes. Schematic representations of competitive and noncompetitive 
immunoassays are shown in Figures 5 and 6. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5 Schematic representation of a competitive immunoassay; analyte is applied first 
followed by a labeled analyte. Higher concentrations of analyte would result in lower 
concentrations of bound labeled analyte and lower detected signal.  
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Figure 6 Schematic representation of a non-competitive immunoassay; a secondary labeled 
antibody is added to detect the interaction. The target antigen binds to the immobilized 
antibody as well as binds to the labeled antibody. Higher detected signal indicates of high 
analyte concentration. 
 
1.3 Antibody 
Antibodies are the key components of an immunoassay; a biomolecule, which has the ability 
to bind foreign harmful antigens (such as bacteria, fungi, viruses, parasites and chemicals) in 
human body through a specific recognition sites in their structures. The binding results in 
forming an immune complex (28), which can then be removed from circulation through 
phagocytosis by macrophages. Lymphocytes are white blood cells able to secret antibodies 
after their stimulation; this takes place through one type of its cells known as plasma cells 
(29). Lymphocytes are considered the major cells involved in the immune system because 
they determine the structure specificity of antibody.  
An antibody or an immunoglubin is a glycoprotein composed of 4 polypeptide chains that 
can be visualized as a Y shape. Each polypeptide chain has an amino terminal group and a 
carboxyl terminal group. Two polypeptides are long (440 amino acids approximately), 
identical and called heavy (H) chains with a molecular mass of 50-75 KDa. The other two are 
shorter (220 amino acids approximately), identical and called light (L) chains with a 
molecular mass of about 25 KDa (30). Moreover, each polypeptide chain consists of a 
constant region (C) and a variable region (V).  
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Light chains can be divided into one variable (VL) and one constant (CL) domain, while the 
heavy chains can be divided into one variable (VH) and three or four constant domains. 
Starting from the amino end to the carboxyl end of polypeptide, constant chains can be 
named CH1, CH2, CH3, and CH4. The variable regions of both heavy and light chains are 
homologous and similar in length; in the same manner the constant region of light chain is 
homologous and similar in length to the constant regions of the heavy chain (31).  
Heavy chains are linked to each other and to the light chains by disulphide bridges, in 
addition to some non-covalent forces such as electrostatic, hydrogen bonding and Van der 
Waals forces. A flexible domain can be found in antibody, which enables the arms of the Y 
shape to be flexible and able to move based on the antigen‘s position. This domain sequence, 
known as hinge region, can be found between the constant regions of the heavy chains CH1 
and CH2.  
Variable domains contain small number of amino acids that are able to identify antigens and 
interact specifically to them. Variable domains differ from antibody to another, giving the 
antibody its unique interacting behavior. As a result antibodies function in different types of 
immune responses, opposing different types of antigens.  
On the other hand, the constant regions do not differ from antibody to another. Nevertheless, 
antibody directed to a certain antigen can be divided into 5 different classes or isotopes, IgG, 
IgM, IgA, IgE and IgD, based on a difference in the amino acid sequence of the constant 
regions of the heavy chains (effector site), which known as γ, μ, α, ξ and δ respectively. This 
difference enables the antibody to function in different stages of the disease (32). Figure 7 
shows a typical structure of immunoglobulin (antibody) protein. 
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Figure 7 Schematic structure of an IgG molecule. An IgG consists of two heavy and two light 
chains that contain several domains: the variable domains variable light (VL) and variable 
heavy (VH) that form the antigen-binding site and the constant domains CL (constant light) 
and CH1–3 (constant heavy) building the framework. The IgG can be furthermore divided 
into the Fab (fragment antigen binding) and Fc (fragment crystallizable), which induce the 
effector functions. Modified from Higel et al. (33)     
 
1.4 Antibody-antigen interaction 
Antibodies are produced when the B lymphoid cells are stimulated by antigen; they are 
capable of detecting and binding a specific conformational region on the antigen (epitope or 
antigenic determinant). The antibody detects the epitope through some amino acid residues, 
mostly aromatic (tyrosine, tryptophan, and phenylalanine). The residues are contained in six 
loops of the amino-terminal region of the antibody (complementarity determining regions) 
(34). Three of these loops are from the light chain and three are from the heavy chain (the tip 
of the Y shaped antibody structure) (Figure 7). This high specific interaction brings the value 
of the antibody up in experimental biology, biomedical research, diagnostics and therapy.  
When antibody and antigen are in a precise alignment to each other, the interaction of both 
proteins takes place and forms the immune complex.  
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The interaction takes place only when the concentrations of antibodies and antigens are 
sufficiently high to ensure the formation of immune complex, more than 50 % of antibody 
and antigen should be bound. The immune complex is mainly stable because of noncovalent 
forces; namely, hydrogen bonding, ionic (coulombic) interaction, hydrophobic interaction, 
Van der Waals forces, and steric repulsion forces. These forces are extremely sensitive to the 
distance between the interacting groups; each of these forces is not strong by itself but when 
they combined, a very tight interaction takes shape (35). Nevertheless the immune complex 
can be detached by applying a high salt concentration, detergent, or non-physiological pH.  
A visible effect such as a 
precipitation reaction, an 
agglutination reaction, or a 
flocculation reaction can be 
observed as a result of the 
antibody-antigen interaction 
(Figure 8) (36). Agglutination 
of Leptospira spp. in the 
microscopic agglutination test 
(37) and precipitation of 
Aspergillus spp. antigen and 
serum antibody in an agar gel 
diffusion test (38) are two examples of visible reactions caused after an antibody-antigen 
interaction.  
Most of immune complexes are not visible; detection of such complexes is significant in vitro 
analysis, thus many techniques have been developed to detect this kind of interaction. The 
immune complex can be detected using a colorimetric reaction (39), or an electrochemical 
reaction (40). Detection can be also performed in a label-free environment; for example, 
quartz crystal microbalance (QCM) device, and plasmon resonance (SPR) device enable the 
detection in real time in label free environment. (41) 
Most commonly used techniques, however, are the labeled-based immunoassays, which 
monitor the interaction after applying a label that produce observable signal (42).  
 
 
Figure 8 Latex agglutination test; visible agglutination 
reaction (right) can be detected after formation of 
antibody-antigen complex and negative control (left) that 
lacks antibody-antigen complex formation. 
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1.5 Lyme borreliosis 
Lyme borreliosis is one of the most common infectious diseases in North America and 
Europe; it is transmitted to human by specific Ixodes spp. ticks. The transmission takes place 
during the tick feeding through injection of the tick saliva. 36 hours, as feeding period is 
usually needed for infection (43).  
In 1982, Burgdorfer and colleagues successfully isolated and detected spirochete bacterial 
species from adult Ixodes dammini. The bacteria showed a specific binding to 
immunoglobulins of patients, who were convalescing from Lyme disease. The bacteria were 
found in the Ixodes midgut, which were collected in an endemic Lyme disease (Shelter 
Island, New York). The bacteria were named later as Borrelia burgdorferi and considered the 
cause of the Lyme borreliosis (44).  
Total of 12 species belong to the genus Borrelia burgdorferi; at least five genospecies are 
pathogenic in human. Borrelia afzelii and Borrelia garinii are the main cause of the disease 
in Europe; Borrelia burgdorferi sensu stricto is a main cause of Lyme borreliosis in North 
America. In addition to Borrelia spielmanii, and Borrelia bavariensis (45).  
Borrelia burgdorferi is phylum spirochetes bacteria with, helically shaped thin long cells, 
outer cell membrane, and flagella (46) The outer cell membrane surrounds the protoplasmic 
cylinder, the inner cell membrane and the peptidoglycan (47). The flagella are located in the 
space between the outer cell and the protoplasmic cylinder parallel to the long axis of the 
organism with average diameter of 18 nm. The flagella give the Borrelia its motility even in 
viscous medium (48). Structure and morphology of Borrelia burgdorferi can be seen in 
Figure 9.  
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Figure 9 Structure and morphology of Borrelia burgdorferi. a Scanning (left) and 
transmission (right) electron micrographs of Borrelia burgdorferi. The helical shape of 
Borrelia (visible in the scanning electron micrograph) is imparted by the periplasmic 
flagella, which can be seen in the cross-sectional view of the spirochaete in the transmission 
electron micrograph. b | Diagram of the spirochaete. Flagellar insertion points are located 
near the termini of the spirochaete. Bundles of flagella wind around the flexible, rod-shaped 
protoplasmic cylinder of Borrelia and overlap in the middle. The outer membrane constrains 
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the flagellar bundles within the periplasm. c | Detailed diagram of flagella. Each flagellum is 
inserted into the cytoplasmic membrane and extends through the cell wall into the periplasm. 
Flagella are multi-component, complex structures. Spirochaetal motility results from 
coordinated rotation of the flagella. Source: figures and caption was adapted from he 
burgeoning molecular genetics of the Lyme disease spirochaete (46). 
 
The life cycle of Borrelia burgdorferi can be concluded in four steps: i) Borrelia occurs first 
in the tick vectors, ii) Borrelia is transmitted to the host, iii) Borrelia occurs in the hosts, and 
iv) it is transmitted to the tick (Figure 10). More details can be found in this review (49). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10 Life cycle of Ixodes tick vectors of Borrelia burgdorferi. Small rodents, such as 
mice, are reservoirs for B. burgdorferi. The tick becomes infected from feeding on a mouse 
and remains infected as it changes to nymph and then adult. The spirochaetes are transmitted 
by infected nymphs to other mice and to humans, which are inadvertent hosts. Deer are 
important hosts for adult ticks, but are not effective reservoirs for B. burgdorferi (50). 
Introduction 
 19 
Three clinical stages could appear and may overlap at the patient of Lyme borreliosis (48): i) 
erythema migrans (EM), a rash increase centrifugally, appears after days to few weeks of the 
tick bite (51), ii) spreading of Borrelia into bloodstream causing clinical signs of the early 
dissemination; many organs may be affected at this stage including nervous system, the 
joints, and the heart; this stage appears after few weeks to months from infection (52), and iii) 
if Lyme borreliosis is not treated, the third stage that appears as chronic organ involvement 
occurs, persistent joint inflammation and joint swelling. In addition, direct involvement of the 
eye could take place at this stage (53). Additionally, other pathognomonic symptoms could 
express the presence of Borrelia infection; namely, lymphadenosis cutis benigna, 
meningopolyneuritis Bannwarth, and acrodermatitis chronica atrophicans. In this case a test 
for Lyme borreliosis detection is recommended. 
 
1.5.1 Laboratory diagnosis of Lyme borreliosis 
 
Laboratory diagnosis is necessary when the patient shows the typical borreliosis symptom, 
EM with fever following a tick bite in an endemic Lyme disease area.  The diagnosis is 
commonly based on the direct or the indirect detection of the infecting agent; Borrelia 
detection can be performed employing four different techniques: i) the direct detection of 
intact Borrelia spirochetes using microscope based observation (54) ii) cultivating of 
Borrelia followed by microscopic detection of spirochetes (55), iii) detection of Borrelia 
specific deoxyribonucleic acid (DNA) sequence using the polymerase chain reaction (PCR) 
(56), and iv) the indirect detection based on measurement of Borrelia specific IgG or 
immunoglobulin M (IgM) antibodies using serological immunoassays (57). In case of Lyme 
borreliosis suspicion, direct microscopic detection of the spirochete Borrelia in clinical 
samples comes as a first approach; however this method is limited in laboratory diagnosis 
because of the limited sensitivity arose from the sparseness of organisms in clinical samples, 
in addition to the subjective interpretation of the microscopy results.  
Alternative approach could be employed for detection is the cultivation of the causative agent 
followed by the microscopic monitoring of the spirochetes; a typical Borrelia culture is 
Barboure-Stoennere-Kelly (BSK) (58), a liquid medium of CMRL-1066 with bovine serum 
albumin fraction V, rabbit serum and N-acetylglucosamine supported with other ingredient; 
the cultivation takes place at 30° to 34°C for up to 12 weeks.  
Introduction 
 20 
The presence of Borrelia spirochetes is then detected in culture supernatant by dark-field 
microscopy or by fluorescence microscopy after a staining step. Culture is a time-intensive 
process; patient should wait up to 12 weeks before being declared positive or negative. Other 
limitations should be considered in such a method; for example, culturing of samples other 
than skin and blood is limited due to the scarcity of organisms, the difficulty in culturing 
some organisms, the slow growth of other organisms and the dangerous to culture other 
organisms. 
The small number of Borrelia in clinical specimen can be overcome through detection of the 
amplified Borrelia DNA in early Lyme disease in skin, cerebrospinal fluid (CSF), and 
synovial fluid samples using the PCR; as disadvantages, diagnosis of blood and CSF samples 
using PCR has shown to be uncertain for laboratory use because of the low sensitivity the test 
showed in this special case (usually, PCR is very sensitive). Also PCR does not differ 
between dead and live organisms, as well as accidental contamination with target DNA could 
take place in laboratory; that would lead to false positive results even after clinical treatment 
(59). Due to their high specificity, the three techniques are still in use. Nevertheless 
developing an alternative has been one main concern in clinical diagnosis; that comes on the 
basis of the shortcomings those conventional methods posses.  
As mentioned above ligand binding assays (serological diagnosis) as an indirect detection 
method mainly comes in laboratory as a confirmatory test due to the high specificity and high 
sensitivity, as well as short time of the test. Hence, most of developed methods can been seen 
based on serological diagnosis. 
 
1.5.2 Serological diagnosis of borreliosis 
 
When a clinical diagnosis suspects a Lyme borreliosis from the symptoms, serological 
diagnosis comes as a confirmatory test. The test aims mainly to detect the immune response 
to the Borrelia burgdorferi antigens, particularly IgG and IgM. Serological diagnosis has 
been considered the only test, which has been approved by the US Food and Drug 
Administration (FDA) for borreliosis diagnosis.  
After the vector bite, the body takes 2 to 6 weeks to produce antibodies against antigens; 
obtaining positive result using serological diagnosis at this stage is infrequent (less than 50 
%).  
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This limited sensitivity in early infection can be neglected since the infection is confirmed by 
the clinically diagnosis after recognition of the presence of EM. After 2-6 weeks, serological 
diagnosis is mainly positive with one tier test; however it might yield false positive results 
that caused by other spirochete infections. Therefore two-tiered serological testing (60) was 
recommended by US Centers for Disease Control and Prevention (CDC) and European 
guidelines (61). Two-tiered testing starts with a sensitive enzyme immunoassay that detects 
IgG or IgM, followed by immunoblotting of the positive or intermediate samples acquired 
from the first test. The enzyme immunoassay should be at least a second-generation test, i.e. a 
recombinant antigen that show low cross reactivity to other non-pathogenic bacteria should 
be used. The two-tiered testing is recommended also in particular when the patients are not 
presenting with EM or the infection took place in area where Lyme borreliosis is not an 
endemic disease. An alternative to the two-tiered testing, a specific and accurate one-tier 
testing could be acquired when a highly specific recombinant antigen or synthetic peptide 
would be utilized. The used antigen should cover the wide antigenic variety of several 
relevant Borrelia subspecies; simultaneously, it should avoid the cross reaction with the other 
non-pathogenic Borrelia strains and other cross-reactive agents.  In addition, the antigen 
should have a measurable immune response from the infected host in all phases of infection 
and should distinguish between fresh, past or healed infection. In the presented work 
recombinant antigens have been used to develop a specific one-tiered testing, which can be 
used as an alternative for the time consuming two-tiered testing. 
 
1.6 Antigens immobilization and carriers  
One main step when developing a new immunoassay is to immobilize antigen on the support 
or carrier surface through a gentle and straightforward coupling procedure. Developed 
immobilization methods have aimed at preserve the structure and function of the 
biomolecules under reaction conditions; also the method should enable a high storage 
stability of the antigen. Immobilization techniques can be generally classified into physical, 
covalent, entrapment, crosslinking, and affinity immobilization (62).  
Physical and ionic adsorption of proteins is one approach, which utilizes some weak binding 
forces, e.g. hydrogen bonds, Van der Waals forces, multiple salt linkages, hydrophobic and 
electrostatic interactions. The non-specifically adsorbed proteins can be removed by washing 
afterwards.  
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This method is considered easy and fast, however, the adsorbed proteins could be detached 
due to a change in pH, temperature or ionic strength, affecting the performance of the assay 
(63). Entrapment of proteins in matrices is another approach that has been also developed for 
protein immobilization. It considers the caging of the proteins within a matrix such as gels, 
polymers, pastes, or inks via covalent or non-covalent bonds. The biomolecules and the 
matrix are well mixed and applied simply on the carrier surface. We can find also the 
crosslinking technique, where the proteins are to be attached to the carrier via bi or 
multifunctional reagents, e.g. glutaraldehyde, bis(diazo)benzidine, tannic acid, or dimethyl 
adipimidate (64).The most used immobilization technique depends mainly on covalent 
bonding. The bond is created through the reaction of reactive groups at the protein surface, 
such as the N-terminus lysine amino groups, hydroxyl, sulfhydryl, or phenolic functional 
groups with corresponding functional groups at the surface of the solid support, carrier (65). 
 
In the present work, two platforms were served as carriers, 3-dimensional polyethylene sinter 
bodies and gold nanoparticles (AuNPs). Polyethylene evolved into a very good candidate as a 
carrier in biotechnology applications, including biosensors and bioassays. This arises as a 
result of its low cost, low energy requirements for processing and its high chemical stability. 
Besides, polyethylene posses a highly optical transparency to the detection wavelength in 
light intensity measurement based devices. Polyethylene can be produced by the 
polymerization of ethene; the polymer surface is naturally inert and highly hydrophobic (66). 
Physical and chemical properties of polyethylene, however, could be controlled during 
production process. This would provide variety of characteristics for the polymer, which can 
be employed in various applications. Numerous techniques were developed to manipulate the 
polyethylene with the desired characteristics during synthesis; for example living or 
controlled alkene polymerization (67), implementation of chain transfer reactions and 
controlled copolymerization of alkene with functional monomer (68).  
Yet, activation and surface modification of the polyethylene low surface energy should be 
performed, boosting the polyethylene adhesion, biocompatibility and hydrophilic properties 
without any effect on its bulk properties. Consequently, a proper surface for biomolecules 
immobilization is provided. Introducing functional groups on the surface of the cheap 
commodity polyethylene has been studied using several techniques. Namely, inducing copper 
(II) ion adsorptivity on polyethylene surface via γ-ray irradiation(69), generating peroxides 
on the surface via ozonation (70), introducing bioactive compounds via ultraviolet light (UV) 
light (71) and oxidation of polyethylene surface using wet chemistry(72).  
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Surface modification based on polymerization of monomeric blocs has been also successfully 
carried out via plasma (73), γ-ray irradiation (74) and UV irradiation.  
Photografting of monomers, mostly polar, using UV light is one of the most convenient 
methods to activate chemical bonds and to introduce functional groups on the polyethylene 
surface. The versatility application of the process is a consequence of the low cost and the 
easy in controlling the grafting process with high density of monomer molecules on the 
surface; this yield on a high and long-term chemical stability of the grafted layer. Likewise, 
UV radiation has a neglected effect on the bulk properties of the polymer and the substrate. 
UV light in its full range of wavelength is generally used to achieve the grafting process; 
nevertheless, it was elucidated that below 300 nm the UV light enhance the initiation of graft 
polymerization (75).  
Photografting can be carried out either in one-step or two-step process. In one-step process, 
the polymer is dipped in a solution that contains both the monomer and the photoinitiator, 
and then it is exposed to the UV radiation, initiating the grafting process (76). While in the 
two-step process, a solution of photoinitiator is added to the polymer and irradiated; 
following, a second step takes place; a solution of the monomer is introduced to the polymer, 
which in turn will be grafted on the polymer surface during irradiation (77). Although the 
overall result of the two processes is similar. The one step process is favorable in industrial 
perspective due to the short time and the easy of performing, while the two-step process is 
preferred in scientific research since the grafting process including the density of grafting 
layer can be controlled.  
The photografting process starts with absorbing the UV light by the photoinitiator; the 
excitation of molecules to a short-lived singlet state takes place and then relaxes to more 
stable triplet state (intersystem crossing) forming bi-radicals; then the bi-radicals abstracts 
hydrogen from the polymer surface leaving the polymer as a macro-radical. The monomer 
could be, eventually, abstracted by the polymer surface forming a new layer of the 
polymerized monomer. In two-step photografting process the photoinitiator first reacts with 
the surface of the polymer surface through radical reaction then it is replaced by the monomer 
afterwards in the second step. A schematic illustration of one-step grafting process can be 
seen in Figure 11. 
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Figure 11 Schematic illustration of one-step UV photografting process. Benzophenone act as 
photoinitiator; it absorbs UV light, turning into radical. The radical abstracts hydrogen atom 
from the polymer surface, exposing active carbon. The active carbon can abstract the 
monomer subsequently, forming a layer of polymerized monomer.  
 
AuNPs as a second platform served as proteins carrier, assisting in developing a new rapid 
serological test. According to the American Society for Testing and Materials (ASTM), 
terminology for nanotechnology ASTM international 2006, nanoparticles can be defined as 
any particles that are synthesized under controlled size and shape with average length of 1 to 
100 nm in two or three dimensions. Nanoparticles possess some unique chemical, optical and 
electrical properties when compared to its relative bulk materials. Among them is the high 
surface-to-volume ratio, which permits the functionalization of nanoparticles with biological 
active components, such as peptides, proteins and DNA. This phenomenon facilitates 
nanoparticles to be utilized in development of many biological applications, such as drug 
delivery (78), imaging (79), development of biosensing applications (80), and improving the 
chromatographic separation of protein (81). Nanoparticles based on noble metal such as gold 
possess a unique property that distinguishes themselves from other nanoparticles, 
semiconductor quantum dots, magnetic nanoparticles and polymeric nanoparticles. AuNPs is 
characterized by its SPR; a phenomenon takes place at the nano-scale level of gold particles.  
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Conduction electrons are triggered to 
collectively oscillate with a resonant 
frequency when certain wavelengths of 
electromagnetic radiation interact with 
its surface (Figure 12). This 
phenomenon is responsible for the 
strong absorption and scattering of 
visible light that incident to the 
nanoparticles, giving the nanoparticles 
its intense color (82). The change in 
size and shape of nanoparticles 
resulted in change in the SPR; this 
explains the ability of AuNPs to 
possess a diversity of light scattering 
and absorbance. As a consequence color of gold nanoparticles can be diverse from red to 
blue. Distance between gold nanoparticles in suspension showed to have a very crucial 
impact on AuNPs color. Decreasing this distance cause a change in SPR, which appear as a 
shift in maximum absorbance of nanoparticles to higher wavelengths. This phenomenon 
enabled AuNPs to be serving as intense label in immunoassay, biochemical sensors, and 
surface-enhanced spectroscopies. This type of colorimetric biosensing methods caught the 
attention because they are simple and promising for point-of-care testing. Mirkin and 
coworkers developed the first established assay based on aggregation of AuNPs for DNA 
detection in 1996 (83). This phenomenon has been exploited since then in different 
applications; namely, detection of thiocyanate (84), detection of cancer cells (85), and 
detection of heavy metals (86). 
When nanoparticles based on noble metal (such as gold) being synthesized, a reducing agent 
and a capping agent are necessary to complete the synthesis process; the reducing agent 
reduce the metal ions to form the inorganic core of the particles while the capping agent is 
responsible for stabilizing the core from aggregation through electrostatic repulsion between 
nanoparticles. Many approaches have been developed for AuNPs synthesis in order to 
improve their stability, biocompatibility, and aqueous dispersion.  AuNPs can be synthesized 
in different shapes and sizes with diameter ranging from 3 to 200 nm.  The most widely used 
method based on the reduction of gold hydrochlorate solution by citrate ions; a method 
Figure 12 Schematic illustration of AuNPs surface 
plasmon resonance. Collective oscillation of 
conduction electrons takes place after interaction 
with the light radiation, resulting in extinction of 
light (absorption and scattering). 
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developed by Turkevich in 1951 (87) and latter optimized by Frens in 1972 (88). In this 
method citrate acts as both a reducing agent and capping agent. The method allows synthesis 
of spherical AuNPs in aqueous solution in the range from 10 to 25 nm smaller particles are 
hard to obtain and bigger particles were clumped. However, other established approaches 
showed the potential to obtain bigger sizes of AuNPs using Turkevich method with some 
modifications.  
Brust and Schiffrin (89) reported another widely used method in 1994 that have the 
advantage of synthesizing small AuNPs in organic solution with 1- 3 nm. The method based 
on using two-phase (water-toluene) reduction of gold hydrochlorate by sodium borohydride 
in the presence of an alkanethiol; this results in the direct synthesis of surface-functionalized 
AuNPs.  
Many other methods have been developed to improve the synthesis of AuNPs including, 
using plant extracts to reduce gold salt and colloidal gold fabrication in what so called ‗green 
synthesis‘ (90), using chemical radiation such as UV and Υ-ray for reduction of gold ions in 
presence of surfactants (91), and reduction of gold salt in presence of polymers which acts as 
a surface coating for the AuNPs that can improve the long-term stability, enhancing 
hydrophobicity, and improving biocompatibility (92).  
Compatible AuNPs surface should be obtained for bio-conjugation purposes. Using 
Turkevich method, synthesized AuNPs possess a high affinity to be modified with 
biomolecules; this comes as a result of the negative charge on the surface (which assumed is 
arising from adsorbed [AuCl2]−
 ions) (93). Also, the biomolecules can be easily attached via 
hydrophobic interaction or via linkers. The attachment can be conducted based on self-
assembling of bi-functional ligand via electronic attraction of positively charged sites on 
biomolecules and negatively charged AuNPs, adsorption through the hydrophobic sites on 
protein binding to the metal surface, or covalent binding of gold to a chemical group (dative 
bonding); the latter ensures the constant binding of protein to the nanoparticle surface and 
ensures the avoidance of possible denaturing of protein. This straightforward 
functionalization of AuNPs supports AuNPs to be used in broad applications; for example, in 
diagnostics as labels, in microscopy as probes, in biosensors as a platform, and in drug 
delivery as carrier. A widely used method for AuNPs functionalization is to fabricate AuNPs 
with monolayer-protected clusters (MPCs) during synthesis; alkanethiolate (C3-C24) is used 
for AuNPs functionalization using Schriffin method (94); subsequently, ligand exchange 
techniques can be used to transfer the AuNPs from organic to aqueous solution; this 
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techniques based on exchange the alkanethilate MPCs with water-thiol-acid molecules. 
Finally, the attachment of the biomolecules could be easily acquired (95).    
In general, the minimum amount of biomolecule needed to prevent AuNPs aggregation is 
added plus 10-20 % excess for the functionalization process. In addition, a blocking agent, 
such as polyethylene glycol, bovine serum albumin, and solution of dried milk, is added to 
completely coat the remaining free sites on the gold surface; this helps in reduce the 
nonspecific interactions during assay performance as well as assist in stabilizing AuNPs 
colloid. 
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2 Aims and objectives 
In laboratory diagnosis, detection of anti-Borrelia antibodies in sera sample mainly comes as 
a confirmation test for Lyme borreliosis diagnosis. This is as mentioned due to the high 
specificity and high sensitivity of the test as well as its short time. Many assays have been 
developed for serological diagnosis of borreliosis.  
Three major techniques were used for the detection: i) immunofluorescent antibody staining 
(IFA) (96), ii) enzyme-linked immunosorbent assays (ELISA) (97) and iii) western 
immunoblot tests (98). However, most of these assays are time-consuming and some are 
labor-intensive; also ELISA utilizing whole Borrlia burgdorferi as the antigen structure 
yields some false-positive reactions. Thomas B. Ledue developed a fully automated random-
access analyzer, which employs two-step chemiluminescence immunoassay technology for 
Lyme borreliosis diagnosis (99). The system is promising, sensitive, selective, and can be 
used as alternative to conventional immunoassays based on using enzyme for detection. Yet, 
the test could not be considered for point of care testing, where some significant factors 
should be respected such as well-trained personnel able to perform the test and interpret the 
results (100). 
 
Therefore, the aim of this work was to develop new immunoassay platforms for rapid and 
sensitive serological diagnosis of borreliosis. Main goal of the work was to develop a point of 
care test; in addition, the platforms should be transferred to further immunoassays. 
The work aimed also to test two antigens, a recombinant VlsE antigen and the 26-mer peptide 
from the VlsE antigen sixth invariable, C6, region, in the proposed platforms. Both antigens 
induce a strong antibody response that can be detected from early to late phase during the 
disease in humans infected with Borrelia burgdorferi or with European genospecies 
including Borrelia afzelli and Borrelia garlnii. Simultaneous they showed low cross-reaction 
with other non-pathogenic Borrelia strains. 
The objective of the present work was to employ two novel platforms, i) 3-dimensional 
porous polyethylene sinter bodies (3-DPESB) and ii) two-antigen modified gold 
nanoparticles, in a simple and rapid immunoassay for the detection of antibodies directed to 
infectious diseases. 
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Based on the desired objectives, the study included: 
1- Utilizing ABICAPTM technology along with a small 3-DPESB (2 × 2.5 mm) to 
develop a point of care test.  
2- Surface activation of the 3-DPESB for antigens immobilization. 
3- The intention to combine the high specificity of a recombinant fusion protein and a 
modified 3-DPESB to conduct a rapid and easy serological test. The work aimed to 
modify the 3-DPESB with a polysaccharides mannan, which allows fixation of 
genetically designed fusion protein, C6 region of VlsE, fused with Concanavalin A, 
by self-organization. Therefore, choosing of a convenient technique to immobilize 
mannan on the surface was of a main interested in the work. Final step was to 
investigate the proposed platform in the detection of anti-Borrelia antibodies in 
human sera samples; detection should be conducted colorimetrically in an ELISA-like 
manner using HRP labeled secondary antibody.  
4- The direct immobilization of VlsE antigen on the 3-DPESB. Hydrophobic and 
covalent immobilization techniques were proposed to achieve the fixation of antigen 
on the surface, which would be used further in testing human sera samples in an 
ELISA-like manner. Moreover, we aimed to examine different labels, HRP labeled 
antibody, AuNPs modified with protein A, as well as Sudan IV nanoparticles 
modified with HRP enzyme, to improve the sensitivity of the platform.  
5- Investigating the potential to use two-antigen modified gold nanoparticle to obtain a 
rapid one-step serologic test. Work aimed to synthesize different sizes of spherical 
AuNPs followed by its functionalization with two antigens, Protein A and VlsE 
Borrelia antigen. Finally, verifying the feasibility of modified AuNPs in detection of 
antibodies in human sera samples should be performed.  
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3 Experimental: 
3.1 Chemicals:  
If not otherwise mentioned, chemicals were obtained from Fluka, Sigma-Aldrich or Merck, 
Germany, in analytical quality. Benzophenone and 4-dimethylaminopyridine were obtained 
from Merck-Schuchardt, Germany. N,N´-disuccinimidyl carbonate ≥ 95% (NMR), sodium 
acetate anhydrous, anti-human IgG (γ-chain specific)-biotin antibody, mannan from 
Saccharomyces cerevisiae and (3-aminopropyl) triethoxysilane 99%, 11-mercaptoundecanoic 
acid 95%, nitric acid 65%, and N- (3-dimethylaminopropyl)-N`-ethylcarbodiimide 
hydrochloride (EDC) were from Sigma-Aldrich, Steinheim, Germany.  Allyl alcohol 99.5% 
(GC), ethanolamine 99%, and manganese chloride tetrahydrate 99 % were from Fluka, 
Germany. Acetone 99.5%, hydrochloric acid S.G. 1.16 (32%), and methanol were from 
scientific, UK. Ethanol, di-potassium hydrogen phosphate, sodium dihydrogen phosphate, 
sodium carbonate, N-hydroxysuccinimide (NHS),  sodium dihydrogen phosphate dihydrate, 
di-sodium hydrogen phosphate dihydrate, and sodium hydrogen carbonate were from Merck, 
Darmstadt, Germany. Sodium chloride 99.8%, boric acid 99.8%, 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), PUFFERAN® ≥ 99.5%, magnesium chloride 98.5% 
water free, calcium chloride 94%, Coomassie -solution Roti1-Quant, 5 x concentrate, and 
acetic acid glacial 100%, bovine serum albumin (BSA), albumin fraction V, biotin free ≥ 
98% for molecular biology were from Carl Roth, Karlsruhe, Germany. Sodium hydroxide 
99% was from Grüssing, Filsum, Germany.  
Anti-human IgG-HRP and 3,3‘,5,5‘-tetramethylbenzidine (TMB/substrate solution) were 
from Seramun Diagnostica, Heidesee, Germany. ABICAP
TM
 column, ABICAP
TM
 sinter 
bodies, size of 2 × 2.5 mm and pores 100 µm wide, were from Senova Gesellschaft für 
Biowissenschaft und Technik mbH, Germany. 
Blocking solution based on chemically modified and fragmented highly purified casein was 
purchased from Candor, Wangen, Germany. 5.5% casein buffer concentrate (CBC) and 
conjugate buffer [antibody/antigen (poly HRP) conjugate stabilizer (AA1)) were from 
Stereospecific Detection Technologies, Baesweiler, Germany.  
Nanoparticles based on bovine serum albumin (BSA) and Sudan IV, which are conjugated 
with streptavidin and horseradish peroxidase (HRP), particle size: 541 nm, was supplied by 
research center of medical technology and biotechnology (fzmb), Bad Langensalza, 
Germany.  
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Gold (III) chloride hydrate 99.999% trace metals basis, trisodium citrate dehydrate, and silver 
enhance kit (silver enhancer solution A and solution B) were from Sigma-Aldrich, 
Schnelldorf, Germany. Servapor dialysis tubing, MWCO 12000 – 14000, diameter 21 mm 
and pore diameter 25 Å was from SERVA electrophoresis GmbH, Heidelberg, Germany.  
 
3.2 Buffers and solutions 
 Carbonate-bicarbonate buffer (CBB) pH 9.6  
160 ml 100 mM sodium carbonate (Na2CO3) (MW 105.99 g/mol) 
   +    340 ml 100 mM sodium hydrogen carbonate (NaHCO3) (MW 84.01 g/mol) 
 
 Phosphate buffered saline (PBS) pH 7.4 
10.4 mM di–potassium hydrogen phosphate (K2HPO4) (MW 174.18 g/mol) 
1.8 mM sodium di-hydrogen phosphate monohydrate (Na2HPO4.H2O) (MW 
137.99 g/mol) 
150 mM sodium chloride (NaCl) (MW 58.44 g/mol) 
pH adjusted with HCl or NaOH 
 
 Acetate buffer pH 4.8 
200 ml 100 mM acetic acid (CH3COOH) (MW 60.05 g/mol) 
      +    300 ml 100 mM sodium acetate (CH3COONa) (MW 82.03 g/mol) 
 
 Borate buffer pH 7.4   
100 mM boric acid (H3BO3) (MW 61.83 g/mol) 
200 mM sodium hydroxide (NaOH) (MW 39.997)  
pH adjusted by adding NaOH to boric acid solution 
 
 Borate buffer pH 9  
10 mM boric acid (H3BO3) (MW 61.83 g/mol) 
200 mM sodium hydroxide (NaOH) (MW 39.997)  
pH adjusted by adding NaOH to boric acid solution 
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 HEPES buffer pH 7.4  
10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid  (MW 238.31 g/mol) 
1 mM calcium chloride (CaCl2) (MW 110.99 g/mol)  
1 mM manganese chloride tetrahydrate (Cl2Mn.4H2O) (MW 197.91 g/mol)  
1 mM magnesium chloride (MgCl2) (MW 95.22 g/mol) 
pH adjusted by NaOH or HCl 
 
 MES buffer pH 5.5 
100 mM 2-(N-morpholino)ethanesulfonic acid (C6H13NO4S.H2O) (MW 213.25 
g/mol) 
pH adjusted with NaOH 
 
 Phosphate buffer pH 7.4 
50 mM sodium dihydrogen phosphate dihydrate (NaH2PO4)·2H2O (MW 156.007 
g/mol) 
50 mM di-sodium hydrogen phosphate dihydrate (Na2HPO4)·2H2O (MW 177.98 
g/mol) 
pH adjusted with mixing two stock solutions 
 
 Washing solution: 10 mM PBS pH 7.4 + 0.1% BSA + 0.05% tween20  
 
 Antibody dissolving solution: CBC buffer diluted 4 times with PBS buffer.  
 
 Coomassie –solution diluted 5 times with water  
 
 Blocking solution (1): PBS pH 7.4 + 0.2% BSA  
 
 Blocking solution (2): chemically modified and fragmented highly purified casein 
 
 Drying buffer: PBS pH 7.4 + 1% BSA + 5% sucrose   
 
 Discoloration solution: 181 mL water + 19 mL glacial acetic acid + 50 mL methanol 
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3.3 Antigens  
VlsE Borrelia antigen was supplied by Seramun Diagnostica, Heidesee, Germany. Full-
length 56 kDa VlsE Borrelia recombinant antigen was supplied in PBS (0.15 M NaCl), pH 
7.2 - 7.4, Borrelia afzelii. Protein was expressed in E.coli with Glutathione-S-Transferase and 
purified with affinity chromatographic techniques. Purity is > 90% as detected by SDS-
PAGE. 
Concanavalin A-C6 fusion protein was produced in our group. Following is a brief 
description of its production: the genes of Concanavalin A and C6 (VlsE epitope of Borrelia) 
were fused together into the expression vector pET15b according to the procedure described 
in previously published article (101). E. coli BL21 DE3 cells were transformed with the 
genetic material and protein expression was performed under 37° C for 4 h after IPTG 
induction at an optical density of 0,6 at 600 nm. The cells were harvested and the fusion 
protein was derived from the cells via inclusion body purification. After purification, the 
inclusion bodies were dissolved in a buffer containing 6 M guanidiniumhydrochloride, 500 
mM sodiumchloride, 10% (v/v) glycerol in 50 mM PBS buffer at pH 7.5. The protein 
solution was stored at -20 °C till further use.  
 
Protein A-soluble extracellular from Staphylococcus aureus capable of binding to the Fc 
portion of immunoglobulins was from Sigma-Aldrich, Schnelldorf, Germany. 
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3.4 Sera samples 
Sera samples were provided by Seramun Diagnostica, Heidesee, Germany. Samples were 
tested by Seramun Luminescence immunoassay LIA-006 for IgG, positive human-sera anti-
VlsE (IgG), derived from patients with assumed Lyme borreliosis, negative human-sera are 
from normal blood donors. Positive and negative samples are listed in Table 1. 
 
Positive sera samples Negative sera samples 
CL-007 CL-457 
CL-029 CL-360 
CL-040 CL-421 
CL-068 CL-550 
CL-144 CL-551 
CL-146 SB-2207 
CL-149 SB-2013 
CL-154 SB-2019 
CL-156 SB-2022 
CL-235 SB-2039 
CL-264 SB-2028 
CL-268 SB-2030 
CL-271 SB-2023 
CL-272 SB-2040 
CL-274 SB-2035 
CL-053 SB-1974 
Hd3 SB-1976 
 SB-1982 
 SB-1983 
 
Table 1 List of positive and negative sera samples used in assays development. 
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3.5 Instruments 
Instruments that have been used in the work are listed in Table 2. 
 
Instrument Manufacturer 
Bruker ALPHA FTIR spectrometer with 
ATR-measuring unit 
Bruker, Germany 
JEOL JSM-7500F field emission scanning 
electron microscope  
JEOL Ltd. Tokyo, Japan 
Atomic force microscopy JPK Nano 
Wizard  
JPK Instruments, Berlin, Germany 
Atomic force microscopy cantilevers 
(NSC16/ Si3N4/AlBS) 
Micromasch, Estonia 
ABICAP
TM
-photometer with read out at 
650 nm and 520 nm 
Senova Gesellschaft für Biowissenschaft 
und Technik mbH, Germany 
pH meter Lab 850 Schott instruments, Germany 
Heraeus Pico 17 centrifuge Thermo Scientific, Thermo Elektro LED 
GmbH, Osterode, Germany 
Heraeus UV lamp  Original Hanau, Hanau, Germany 
Diaphragm vacuum pump  Vacuubrand, Wetheim, Germany 
Shimadzu UV-2401 spectrometer Shimadzu Suzhou Instruments, Suzhou, 
Jiangsu, China 
Jenway Genova plus life science 
spectrophotometer fitted with micro-cuvette 
holder 
Bibby Scientific, UK 
 
Vortex Yellow Line TTS2 
 
IKA, Wilmington, USA 
 
Plasmonic SPR device Plasmonic Biosensor AG, Wallenfels, 
Germany 
 
 
 
Table 2 List of used instruments in the presented work. 
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4 Methods 
4.1 UV irradiation of 3-dimensional polyethylene sinter bodies (3-DPESB) 
Polyethylene sinter bodies have been activated using UV irradiation. The activated sinter 
bodies could be further used for covalent immobilization of biomolecules. Activation was 
established based on photografting of 2-propenol; 2-propenol in turn would form polyalcohol 
groups on the surface, exposing active hydroxyl groups. 3-dimensional polyethylene sinter 
bodies (3-DPESB) with dimensions of 2 × 2.5 mm were used in all steps. The presented 
method was used for the functionalization of 13 sinter bodies jointly as follow: firstly, the 3-
DPESB were washed with 96% ethanol for 10 min under reduced pressure to remove any 
impurities. Then, 3-DPESB were incubated in a reaction mixture of 2 ml methanol containing 
3% (w/v) of benzophenone and 0.5 ml of 2-propenol. The solution was placed with stirring 
for 6 h in front of a 400 Watt UV lamp that emits UV light at 254 nm. Irradiation of the 
samples was carried out at room temperature. After UV irradiation, the 3-DPESB were 
washed 3 times with methanol followed by washing 3 times with double distilled water each 
for 5 min under reduced pressure while stirring. Finally the sinter bodies were dried at 40° C 
for 2 h. During UV irradiation, partially evaporation of methanol was observed, which was 
compensated by addition of 0.5 mL methanol after 3 h. 
 
4.2 Characterization of the UV treated 3-DPESB   
Surface characterization of the UV treated 3-DPESB was performed using Fourier transform 
infrared spectroscopy (FTIR), scanning electron microscopy (SEM) and atomic force 
microscopy (AFM). FTIR spectra (Bruker ALPHA FTIR spectrometer with ATR-measuring 
unit) were collected in the 375 – 4000 cm-1 region with a resolution of 4 cm-1. Typically 24 
scans were collected to obtain sufficient signal to noise ratio. Microscopic visualization of the 
surface was carried out using a JEOL JSM-7500F field emission scanning electron 
microscope (SEM) at an accelerating voltage of 5 kV. AFM measurement of the polyethylene 
surface was performed using the JPK Nano Wizard. AFM cantilevers (NSC16/ Si3N4/AlBS) 
with ultra-sharp tips and a length of about 230 mm were used. The resonance frequency was 
170 kHz and the nominal force constant was 45 N/m. The measurements were done in 
intermittent contact mode under dry conditions. 
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4.3 Covalent immobilization of mannan on the UV treated 3-DPESB 
Firstly, the formed polyalcohol-layer was stabilized by a silane layer. 3-DPESB were 
incubated in 1% (v/v) APTES in 2 mL dry acetone for 10 min under reduced pressure while 
stirring. The 3-DPESB were then dried at 40° C for 2 h and stored in a desiccator before 
further use.  
To allow a smooth immobilization of the mannan, mannan hydroxyl groups were activated 
firstly following a slightly modified protocol from Miron and Wilchek, which was deduced 
from the Zalipsky method (102). In brief, 30 mg of mannan was dissolved in 3.5 mL of dry 
dioxane. The solution was carefully heated in a water bath until complete dissolution of the 
mannan. Then, 6 mM of DSC solved in 1 mL dry acetone was added to the mannan solution 
and finally 6 mM of 4-dimethylaminopyridine in 1 mL of dry acetone was added in aliquots 
during 1 h. The solution was stirred for 6 h at room temperature. Precipitate of succinimidyl 
carbonate (SC)-mannan was obtained by addition of 2 volumes of diethyl ether and the 
precipitate was re-dissolved in dry acetone.  
This step was repeated two times more (last step without dissolution in acetone). The 
resulting solid product was dried under reduced pressure and stored in the refrigerator until 
used. The 3-DPESB with the freshly prepared silane layer were incubated with the SC-
mannan in 0.1 M MES buffer pH 5.5 while stirring overnight at 4° C; this results in covalent 
binding of mannan to the surface (Scheme 1). For each 3-DPESB, 0.75 mg mannan was used 
for immobilization. Afterwards, the 3-DPESB were incubated for 1 h with 80 mM 
ethanolamine in 2 mL MES buffer to passivate all active ester groups followed by blocking 
further unspecific binding sites using 2 mL of the casein based blocking solution 2 for 2 h. 
Finally, the 3-DPESB were dried under reduced pressure for 2 h and stored in a desiccator 
before further use.  
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Scheme 1 Surface functionalization of polyethylene using UV light followed by APTES 
coating and mannan immobilization. 
 
4.4 Covalent immobilization of VlsE antigen on the UV treated 3-DPESB 
For covalent immobilization of VlsE antigen on UV treated 3-DPESB, primary activation of 
hydroxyl groups on 3-DPESB surface was carried out following Miron and Wilchek‘s 
protocol (102). Activation was accomplished after incubating the 3-DPESB in a solution of 
1.5 mL of dry dioxane, 0.5 ml 6 mM of N, N´-disuccinimidyl carbonate solved in dry acetone 
and 0.5 ml 6 mM of 4-(dimethylamino) pyridine in dry acetone; the latter was added in 
aliquots during 1 h. The solution was gently stirred for 6 h at room temperature. The 3-
DPESB were then dried under reduced pressure. 3-DPESB were finally incubated overnight 
at 4 °C with VlsE antigen (0.5 μg for each sinter body) in MES buffer pH 5.5 (Scheme 2).  
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Active carbamate groups were passivated using ethanolamine. 3-DPESB were incubated with 
40 mM ethanolamine in 2 mL MES buffer pH 5.5 for 35 minutes. Next, 3-DPESB were 
washed two times 5 minutes each with MES buffer, and finally, the free unspecific binding 
sites were blocked after 75 min incubation in 2 ml PBS buffer pH 7.4 containing 0.5% BSA 
and 5% sucrose.  The functionalized 3-DPESB were dried under reduced pressure and stored 
at 4 °C until used for further experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2 Surface functionalization of polyethylene using UV light followed by antigen 
coating using amine-coupling procedure. 
 
4.5 Hydrophobic immobilization of VlsE antigen on the surface of 3-DPESB 
Hydrophobic immobilization of VlsE antigen on the surface of the 3-DPESB was performed 
based on a previously published procedure with some modifications (103). In a brief, the 
sinter bodies were washed with 96% ethanol for 10 minutes followed by 10 minutes washing 
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with 50% ethanol in water. 3-DPESB were washed 3 times 10 minutes each with 0.1 M 
carbonate-bicarbonate buffer pH 9.6. Next, 3-DPESB were incubated with the VlsE antigen 
in the carbonate bicarbonate buffer over night; 0.3 μg of antigen for each sinter body was 
used. The 3-DPESB were incubated for 1 h in the blocking solution 1 to block the free 
unspecific sites followed by two hours incubation in the drying buffer. Finally, 3-DPESB 
were dried under reduced pressure and stored at 4° C until used for the assay. All 
immobilization steps were carried out under reduced pressure with stirring at room 
temperature. 
 
4.6 Gold nanoparticles synthesis  
AuNPs was synthesized after the reduction of gold hydrochlorate solution using Turkevich‘s 
method (87). Briefly, glassware was firstly carefully cleaned using hydrochloric acid and 
nitric acid in a volume ratio 3:1, respectively. Then, the glassware was rinsed with deionized 
water and finally dried in an oven at 100 °C for one hour before use. Using a reflux process 
in order to prevent evaporation during the synthesis, a solution of 0.612 mM sodium citrate 
(50 ml of double distilled water) in three-necked round-bottomed flask was heated with 
vigorous stirring until boiling. 1 ml of gold (III) chloride hydrate solution was added 
afterwards; 19 mM, 20.5 mM and 23 mM were used to synthesize 20, 30, and 40 nm 
particles, respectively. The solution was kept boiling for 10 min. The heating system was 
switched off and the solution was kept stirring for 30 min. The cold solution was stored at 4 
°C until further use.  
 
4.7 Hydrophobic functionalization of gold nanoparticles with protein A 
30 nm AuNPs was functionalized with protein A in order to serve as a label in integration 
with the polyethylene sinter bodies‘ platform. Adsorption of protein A was carried out 
following a procedure developed by Thobhani (104). Firstly, the colloidal gold solution was 
dialyzed for 24 hours in distilled water. The pH of 2 mL dialyzed gold solution was adjusted 
between 7 and 7.5 using about 1 μL 0.2 M NaOH and later centrifuged for 30 min at 3500 
rpm. The supernatant was discarded and the gold pellets were re-suspended in 2 mL 100 mM 
borate buffer pH 7.4 containing 20 μg mL-1 protein A. The resulting suspension was gently 
stirred for 30 min in dark at room temperature; following, 200 μL 10% BSA in borate buffer 
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pH 7.4 was added and stirred further for 15 min. The suspension was centrifuged two times 
for 30 min at 3500 rpm. The supernatant was discarded and the gold pellets were re-
suspended in borate buffer pH 7.4. After second centrifugation, gold pellets were re-
suspended in storage buffer (0.5 mL 100 mM borate buffer pH 7.4 containing 0.1% BSA). 
 
4.8 Evaluating the feasibility of AuNPs modification with protein A using SPR 
device 
Plasmonic SPR device was used 
to evaluate the feasibility of the 
AuNPs modification with protein 
A. The working principle of the 
used plasmonic instrument 
(Wallenfels, Germany) is based 
on the SPR technique (Figure 13). 
An optical method in which the 
refractive index of a very thin 
layer of gold (50 μm) adsorbed on 
a metal sensor surface is 
measured. As the analyte binds to 
the ligand immobilized on the 
surface, the mass increases; as a 
result the refractive index increases (105). The change in the refractive index causes a change 
in resonance angle in turn, which can be measured in real time. The result can be plotted as a 
response or resonance units versus time. In our experiments AuNPs modified with protein A 
was added after antibody-antigen interaction. The interaction of AuNPs to antibodies could 
be monitored, confirming the feasibility of the nanoparticles for further experiments.  
 
OspC Borrelia antigen was first immobilized by hydrophobic adsorption on highly 
hydrophobic SPR prism coated with octadecyltrimethoxysilane (C18 chip). C18 can be 
immobilized following a protocol published by Höbel et al. (106). Briefly, SPR gold prism 
was cleaned in acetone for 10 min followed by a rinsing step in Millipore water. The gold 
surface was incubated afterwards in a mixture of 0.1 M KOH and 30% H2O2 (1:1, v/v) for 20 
 
Figure 13 Surface plasmon resonance principle and a 
typical sensogram of resonance signal change with 
time. Refractive index of gold layer changes, as the 
analyte binds to the ligand. The change can be 
measured as resonance units. 
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min at 60 °C. The surface was rinsed with water and then dried under vacuum. The gold 
surface was incubated in octadecyltrimethoxysilane (1% w/w in toluene) for 6 h at room 
temperature on a shaker (250 rpm). The prism was then rinsed in toluene, methanol, and 
water respectively. Finally, the prism was dried under reduced pressure until used. 
Using the C18 chip, an immunoassay has been conducted as follow: 10 μL 500 μg mL-1 
OspC antigen in PBS buffer (0.15 M, pH 7.4) was injected to the SPR chip and incubated for 
15 min. Surface was washed with PBS to remove any unbound antigens. Following, 10 μL 
200 μg mL-1 BSA was added to block the free unspecific binding sites on the chip surface. 10 
μL positive human serum, 100- fold dilution, was added subsequently, and finally, 10 μL of 
the AuNPs suspension modified with protein A was added (Figure 14). As a control, 10 μL 
AuNPs modified (blocked) with BSA was added after serum sample.  
 
 
 
 
 
 
 
 
 
Figure 14 A schematic representation of SPR immunoassay used to evaluate the feasibility of 
AuNPs modification with protein A. AuNPs attached to the surface due to a specific 
interaction between protein A and antibody. AuNPs blocked with BSA result in no binding 
response. 
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4.9 Two-protein modified gold nanoparticles preparation 
To accomplish the second platform, AuNPs (20, 30, and 40 nm) were covalently modified 
with two antigens, protein A and Borrelia VlsE. Prior to antigen immobilization, AuNPs was 
capped with 11-mercaptoundecanoic acid as follow: NaOH 0.2 M was used to adjust the pH 
of 2 mL gold between 7 and 7.5; the solution was centrifuged for 40 min at 4000 rpm. The 
supernatant was discarded and the pellets were re-suspended in 2 mL double distilled water. 
To the 2 mL suspension, 4 μL of 0.2 M NaOH was added; following, 5 μL of 1mg mL-1 11-
mercaptoundecanoic acid (dissolved in ethanol) was slowly added while stirring. The 
solution was gently stirred for two hours at room temperature followed by stirring 24 h at 4 
°C. Gold suspension was finally cleaned after two times centrifugation for 40 min at 4000 
rpm and the pellets were re-suspended in 10 mM borate buffer pH 9.  
Immobilization of the two antigens was achieved using EDC/NHS coupling procedure. 10 μL 
1 mg mL
-1
 VlsE and 12 μL 1 mg mL-1 protein A were added to a 2 mL carboxylated 
nanoparticles. A freshly prepared mixture of 10 μL 0.2 mM NHS and 5 μL 0.25 mM EDC, 
which have been dissolved in 10 mM borate buffer pH 9, was directly added afterwards. The 
solution was gently stirred over night at room temperature. Next, the suspension was 
centrifuged two times at 4000 rpm for 40 min and the pellets were re-suspended in 10 mM 
borate buffer pH 9. Finally the gold pellets were re-suspended in storing buffer, 0.5 mL 50 
mM phosphate buffer pH 7.4 containing 1.5 mg bovine serum albumin. Figure 15 illustrates a 
schematic representation of AuNPs surface modification, followed by antigens 
immobilization. 
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Figure 15 Schematic representation illustrates the modification of AuNPs with VlsE Borrlia 
antigen and protein A. AuNPs capped first with MUA; following, antigens were immobilized 
using EDC/NHS coupling procedure. 
 
4.10 Assay workflow using VlsE-modified 3-DPESB (detection by HRP labeled 
secondary antibody and Sudan IV-streptavidin-HRP-nanoparticles). 
After modifying the 3-DPESB with VlsE antigen, borreliosis positive and negative human 
sera were applied to evaluate the performance of the platform. Firstly, the functionalized 3-
DPESB was placed inside a polycarbonate cartridge on top of an unmodified 3-DPESB, 
which has been passivated with 1% BSA solution (ABICAP
TM
, Figure 16). Alternatively a 
pipette tip of a volume of 1 mL can be used in order to perform the entire assay in this tip. 
The sera were either diluted 1000-fold (5.5% CBC buffer) when VIsE antigen 
hydrophobically immobilized or 500-fold when VIsE antigen covalently immobilized.  
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200 µL of the diluted serum sample was always loaded to the ABICAP
TM
 column. The 
colorimetric detection of immune interaction was sequentially performed using ABICAP
TM 
photometer. The assay workflow was conducted using HRP labeled antibody and 
nanoparticles based on Sudan IV for detection. 
 
 
 
 
 
 
 
 
 
 
Figure 16 Assay set up. 2 × 2.5 mm 3-DPESB were placed inside a small column or a pipette 
tip. Optical density after HRP enzymatic reaction can be measured at 650 nm using 
ABICAP
TM
 photometer. HRP secondary antibody or Sudan IV nanoparticles modified with 
HRP were used for detection. 
 
Firstly, detection using HRP labeled antibody was performed in integration with both 3-
DPESB modified with hydrophobic adsorption and 3-DPESB modified with covalent 
bonding; the detection was pursued after serum loading as follow: applying 250 μL of HRP 
labeled antibody (1 µg mL
-1
) in (AA1) buffer, equilibration of the 3-DPESB using 250 μL 
acetate buffer pH 4.8, and then loading of TMB substrate; finally, 250 μL acetate buffer pH 
4.8 was loaded (Figure 17). Detection using Sudan IV nanoparticles modified with HRP was 
only used with the covalently modified 3-DPESB; detection was pursued after serum loading 
as follow: 250 µL 1000-fold dilution of biotinylated primary antibody (0.6 mg mL
-1 
protein 
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content), loading of 250 μL of nanoparticles diluted in PBS buffer pH 7.4 with the desired 
dilution (100 – 133-fold). Equilibration of 3-DPESB with 250 μL acetate buffer pH 4.8 
followed by loading the TMB substrate was then conducted; Finally 250 μL acetate buffer pH 
4.8 was added (Figure 18). The incubation times for the serum, labeled secondary antibody or 
nanoparticles, and the substrate TMB were 3 min each. Washing steps using washing buffer 
were performed after each step. The optical density was quantified using the ABICAP
TM
 
photometer at 650 nm in triplicate. Raw data were processed by ORIGIN
TM
 software 
package. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17 Borreliosis assay on antigen coated 3-DPESB. HRP labeled antibodies was used 
for detection. The optical density of the resulting blue TMB-precipitate can be measured at 
650 nm. 
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Figure 18 Borreliosis assay workflow on antigen coated 3-DPESB. Sudan IV-HRP 
nanoparticles was used for detection. Red nanoparticles can be measured at 520 nm; 
differently, the blue TMB-precipitate can be measured at 650 nm. 
 
4.11  Assay workflow using VlsE-modified 3-DPESB (detection by gold 
nanoparticles). 
Gold nanoparticles was used for detection in integration only with 3-DPESB that have been 
modified using hydrophobic adsorption. In the here case, 200 μL 250-fold dilution of serum 
sample was applied, instead, to the ABICAP
TM 
column enclosing the 3-DPESB followed by a 
washing step with 250 μL washing buffer; 200 μL protein A-colloidal gold solution (5-fold 
dilutions in PBS buffer) was loaded subsequently. Finally, the optical density was measured 
at 650 nm.  
Silver enhancer solution was used to enhance the signal as follow: 150 μL of silver enhancer 
solution (silver enhancer solution A and silver enhancer solution B, 1:1) was loaded after 
protein A-colloidal gold (Figure 19). Following, a washing step with double distilled water 
was needed. The incubation times for the serum and AuNPs were 3 min each.  
Washing step using washing buffer was performed after serum loading. Finally measurement 
of the optical density was conducted at 650 nm in triplicate. Raw data were processed by 
ORIGIN
TM
 software package. 
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Figure 19 Borreliosis assay workflow on antigen coated 3-DPESB. AuNPs modified with 
protein A was used for detection. AuNPs or metallic silver absorbance can be measured at 
650 nm. 
 
4.12 Assay workflow using mannan-modified 3-DPESB (detection by HRP 
labeled secondary antibody) 
Firstly, the mannan-modified 3-DPESB was fixed inside an ABICAP
TM
 cartridge above an 
unmodified sinter body as spacer, which has been previously washed with casein based 
blocking solution 2. The spacer adjusts the position of the 3-DPESB during the optical 
density measurements. 250 µL of the fusion protein solution (3 µg mL
-1
, consisting of the 
lectin binding domain ConA and the Borrelia surface antigen C6) in 10 mM HEPES buffer 
pH 7.4 was loaded to the cartridge; the ConA part interacts specifically with the immobilized 
mannan, while the antigen part is free for serum diagnosis. For analysis, 250 µL of 1000-fold 
diluted human serum in 5.5 % CBC was loaded to the cartridge (107). The detection was 
performed as follow: applying 250 μL of HRP labeled antibody (1 µg mL-1) in (AA1) buffer, 
equilibration of the 3-DPESB using 250 μL acetate buffer pH 4.8, and then loading of TMB 
substrate; finally, 250 μL acetate buffer pH 4.8 was loaded (Figure 20). The incubation times 
for the fusion protein, serum, labeled secondary antibody and the substrate TMB were 3 min 
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each. Washing steps using washing buffer were performed after each step. Optical density 
was measured at 650 nm in triplicate. Raw data were processed by ORIGIN
TM
 software 
package. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20 Borreliosis assay workflow on mannan-coated 3-DPESB. The fusion protein is 
caught by the mannan, exposing the antigen part for antibodies detection. HRP labeled 
antibody was used for detection. Blue TMB-precipitate can be measured at 650 nm. 
 
4.13 Assay setup using the two-antigen modified gold nanoparticles  
100 μL phosphate buffer pH 7.4 containing the serum sample with the desired dilution was 
loaded in a micro-cuvette; 20 μL of modified AuNPs was then added to the solution. The 
solution was incubated at room temperature until measurements (Figure 21). UV–vis spectra 
were collected on a Shimadzu UV-2401 spectrometer for the qualitative analysis. Absorbance 
intensities of AuNPs were measured at 590 nm for quantitative analysis using Genova plus 
life science spectrophotometer fitted with micro-cuvette holder. Experiments were performed 
in triplicate. Raw data were processed by ORIGIN
TM
 software package. 
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Figure 21 Aggregation of gold nanoparticles as a consequence of antibodies interaction with 
the immobilized antigens. As a result coupling of the SPR of the adjacent particles takes 
place and aggregation appears as a change in color from red to blue.  
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5 Results  
5.1 Activation of 3-DPESB using UV photografting  
Firstly, different amounts of 2-propenol were tested in order to select a convenient 
concentration, which results in monomer‘s grafting. Best results were found, if 2-propenol 
makes up to 25% volume of the reaction mixture, while volume ratios like 1:1 and strongly 
diluted solutions like 5% of 2-propenol did not give any advantage in the obtained FTIR 
spectra. It is assumed that the ratio between the used benzophenone and the 2-propenol is of 
importance. In summary, it turned out that 25 % of 2-propenol is sufficient for the following 
derivatization steps. Different irradiation times were tested additionally for photografting of 
2-propenol in order to find the optimal loading with OH-groups. 3-DPESB were treated for 
1h, 3h and 6h followed by FTIR analysis (Figure 22). 
 
 
 
 
 
 
 
 
 
 
 
Figure 22 FTIR spectra after 2-propenol photografting on 3-DPESB as a function of time. 
Unmodified 3-DPESB (a), 1h UV-irradiation (b), 3h UV-irradiation (c), and 6h UV-
irradiation (d). 
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It is clearly visible that after 3h and 6h of irradiation OH-related absorption bands appeared. 
One broad band is located between 3720 and 3200 cm
-1
, centered at about 3450 cm
-1
, which 
could be attributed to O–H stretching of alcohols and another band located between 1135 and 
1000 cm
-1 
could be assigned to C–O stretching of alcohols. 
The scanning electron microscopy images of the unmodified 3-DPESB and the UV treated 3-
DPESB with 2000-fold magnification (scanned area10 µm x 10 µm) can be shown in Figure 
23. 
 
 
 
 
 
  
Figure 23 Scanning electron microscopy (SEM) images of unmodified 3-DPESB (a), UV 
modified 3-DPESB and one place with a multilayer (b) and UV modified 3-DPESB with 
uniform coating (c); scanned area (10 × 10 µm). 
 
Atomic force microscopy measurements (scanned area10 µm x 10 µm, resolution was 512 x 
512 pixels) that confirm the SEM results are given in Figure 24.  
 
 
 
 
 
Figure 24 Atomic force microscopy (AFM) images of unmodified 3-DPESB (a), UV-modified 
3-DPESB and one place with a multilayer (b) and UV-modified 3-DPESB with uniform 
coating (c); measured area (5 × 5 µm). 
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By both techniques, the surface of the unmodified 3-DPESB (23a, 24a) has been significantly 
modified after UV irradiation and photografting (23b, c; 24b, c). The so modified 3-DPESB 
were covered with some kind of cross-linked structure, which can be explained by 
polymerization of 2-propenol. However, polymerization is not even over the entire surface. 
At some places, coating seems to be more or less regular (Figures 23c and 24c). At other 
places, a rather thick multilayer has been formed, which might be physically instable (Figures 
23b and 24b). The reason for punctual multilayer formation could not been found but might 
be supported by longer exposure times. 
 
5.2 Silanization of UV treated 3-DPESB by APTES for mannan immobilization 
In the next step, the UV treated 3-DPESB surface was grafted with APTES for mannan 
immobilization (Scheme 1). By this procedure, amino groups for further immobilization steps 
were introduced. Detection of amino groups and its distribution on the surface was carried 
out utilizing Coomassie Brilliant Blue Dye-G250 absorption at 520 nm in a so called ‗protein 
quantitation assay‘ according to Bradford following a protocol published by Kehrel et al. 
(108). The silanized 3-DPESB were placed right above a spacer sinter body inside a cartridge 
(compare Figure 16), sinter bodies were wetted by 250 μL 50% aqueous ethanol solution 
followed by incubation with 250 μL Coomassie–solution for 5 min.  After washing, optical 
density at 520 nm was determined (Figure 25). The photometer was adjusted with one blank 
3-DPESB wetted with 50% ethanol. Unmodified (without photografting) 3-DPESB but 
treated with APTES as well as unmodified 3-DPESB without any treatment were used both 
as a control. In the presence of amino groups, a deep blue color occurs (Figure 25-c). The 
color distribution seems to be rather homogenous indicating the presence of amino groups 
over the entire surface. Additionally, 3-DPESB were dissected to control color development 
inside the sinter bodies; the color distribution was found to be rather regular. The two 
controls (Figure 25a and 25b) exhibited a much weaker coloration, which can be explained 
by unspecific binding of the dye (Figure 25a) or a partial APTES coating even without any 
hydroxyl groups at the 3-DPESB‘s surface (Figure 25b).  
 
 
 
Results 
 54 
1 2 3
0.0
0.5
1.0
1.5
2.0
2.5
O
p
ti
c
a
l 
D
e
n
s
it
y
 (
A
U
)
Sample
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 25 Optical densities of 3-DPESB after staining of the APTES-layer by Coomassie 
Brilliant Blue Dye-G250. Unmodified 3-DPESB (1 and a), unmodified 3-DPESB treated with 
APTES, but without photografting step (2 and b) and UV- modified 3-DPESB with APTES (3 
and c). 
The functionalized 3-DPESB showed an optical density of about 1.56 with standard deviation 
of ±0.20, the unmodified 3-DPESB treated with APTES showed a signal at about 0.70 with 
standard deviation of ±0.05 and the unmodified 3-DPESB with no treatment gave an optical 
density of 0.34 and standard deviation of ±0.05. These differences between these three 
measurements are significant, indicating a successful coating with APTES for the 2-propenol 
modified surface. However, APTES can be also grafted to unmodified 3-DPESB to a certain 
extend. But the latter experiment as depicted in Figure 25b gave a much lower loading with 
amino groups as it could be obtained after photografting (Figure 25c). 
Results 
 55 
5.3 Mannan coating  
To get the 3-DPESB ready for the assay as depicted in Figure 20, a mannan coating is 
necessary. Mannan can be covalently immobilized by acid amide binding. Therefore, SC-
mannan seems to be suitable (Scheme 1). This activation prior to immobilization is necessary 
to allow a smooth immobilization of the carbohydrate. Mannan has been chosen because it is 
chemically stable, shows low unspecific binding and allows attachment of lectins by self-
organization. After mannan immobilization, free amino groups were blocked by 
ethanolamine and unspecific binding sites were passivated by a blocking solution.  The so 
prepared mannan-coated 3-DPESB should be stored over several months and can be loaded 
by the fusion protein shortly before usage.  
 
5.4 Serological diagnosis using mannan modified 3-DPESB 
The workflow of the assay is depicted in Figure 20.  Firstly, the ConA-C6 fusion protein has 
been applied shortly before the assay was performed. This protein displays a lectin-binding 
site on one end allowing immobilization on the mannan surface by self-organization and a 
specific antigen structure at the other end facilitating anti-Borrelia-IgG-detection. In the final 
detection step, anti-IgG-antibodies coupled to HRP were applied and TMB was used as color 
reagent. 
Results are shown in Figure 26. A blue TMB-precipitate was produced when Borreliosis-
positive sera were applied (Figure 26a) while only little coloration was visible when negative 
sera (Figure 26b) were added. Also the two negative controls were more or less colorless 
(Figure 26c, d).  
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Figure 26 Color development obtained after HRP detection. Cartridges are filled with an 
unmodified spacer followed by the probe. Two positive sera (a), two negative sera (b), two 
positive sera with control 1, 3-DPESB without photografting and silanization (c), and two 
positive sera with control 2, 3-DPESB without fusion protein (d). 
 
Quantitative analysis of a larger variety of real serum samples is displayed in Figure 27. As 
indicated by the horizontal cut-of-line, a differentiation between positive and negative sera, 
which is important for borreliosis therapy, can be clearly deduced from obtained data. Again, 
two controls were introduced leaving out an immobilization step or the fusion protein. 
Differences between positive and negative sera were significant, meaning that it is unlikely 
that a false-positive or false-negative result occurs. 
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Figure 27 Results of the borreliosis assay with real human sera. Positive sera (1,2,3,4), 
negative sera (5,6,7,8), control 1 (9,10,11,12; 3-DPESB without photografting and 
silanization) and control 2 (13,14; 3-DPESB without fusion protein). 
 
5.5 Serological diagnosis using hydrophobically modified 3-DPESB  
The used polyethylene has a rather high affinity to proteins; this in turn allows a rather easy 
hydrophobic immobilization of VlsE antigen on the 3-DPESB. With a special washing 
routine, VIsE could be adsorbed to the 3-DPESB surface in sufficient amounts; that 
contributes consecutively in enhancing the assay sensitivity. After loading sera samples, two 
labels were used for detection: i) HRP labeled secondary antibody and ii) gold nanoparticles 
modified with protein A. Based on the used label, assay optimal conditions have been 
changed; this includes the concentration of immobilized antigen as well as the dilution of 
serum sample. Firstly, the optimum amount of VlsE antigen needed for immobilization was 
investigated. Using the adsorption immobilization procedure mentioned in section 4.5, 
concentrations of 1, 0.5 and 0.3 μg per sinter body were tested. 
Results 
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5.5.1 Detection using HRP secondary labeled antibody 
Using an ELISA like assay, 500-fold dilution of sera samples were analyzed first using the 
prepared 3-DPESB to select the optimum amount of the immobilized VlsE. When 1 or 0.5 μg 
of VlsE antigen was immobilized using the hydrophobic adsorption technique, some positive 
samples resulted in optical densities higher than the detection range of the ABICAP
TM
 
photometer (2.5 AU). While immobilization of 0.3 μg of VlsE antigen could regulate the 
optical densities of the positive serum samples in the detection range. As a next step, 
approximate anticipation of the optimum serum dilution was tested using 0.3 μg VlsE 
modified 3-DPESB. Different dilutions of two positive samples were tested; obtained signals 
can be seen in Figure 28.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28 Calibration curves of two positive sera. Different dilutions of sera were tested with 
0.3 μg VlsE modified 3-DPESB. Highlighted spots are related to 1000-fold dilution (n=3). 
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Results showed that between 500-fold and 2000-fold dilution, the detection signals were 
obtained between 2.3 and 0.84. Serum dilutions above 2000- fold resulted in low signals, 
which might not yield convenient signal when other positive samples are being tested. 
Dilutions below 500- fold resulted in signals out of the detection range. Consequently, 1000-
fold dilution as an optimum was chosen for further experiments. It must be pointed out that 
the absolute amount of antibodies in the sera, which is directed against VIsE cannot be 
determined. In these cases, the dilution factor of the sample is a value for sensitivity.  
Using the optimized conditions, 17 positive and 20 negative real human sera were tested. 
Results were summarized with some examples of the obtained 3-DPESB after TMB color 
reaction in Figure 29. One control was introduced leaving out the immobilization step. The 
controls as well as the negative sera were display with more or less colorless.  In contrast to 
the positive samples, which appear with dark blue color, indicating the presence of the 
infection.  
As indicated also here by the horizontal cut-of-line, a differentiation between positive and 
negative sera can be clearly deduced from obtained data. For 16 of the 17 positive sera there 
is a clear differentiation from the negative sera. There is only a problem with sample 11, 
which is false negative.  
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Figure 29 (a) Color development of 4 positive sera (1-4) and 4 negative sera (5-8) and one 
control (9) after performing the assay on 3-DPESB that have been modified using 
hydrophobic adsorption and (b) optical densities of 17 positive and 20 negative sera samples 
tested on 3-DPESB modified with VlsE antigen using hydrophobic adsorption. Detection was 
conducted using HRP secondary labeled antibody; cutoff was found at 0.2 (n=3). 
 
 
 
 
 
 
 
a 
b 
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5.5.2 Evaluating the feasibility of AuNPs modification with protein A for detection 
Protein A, which binds to the Fc part of antibodies, was immobilized on gold nanoparticles. 
Interaction of protein A on AuNPs surface with anti-Borrelia antibodies could be monitored 
using SPR device, confirming the feasibility of the nanoparticles as a label for ABICAP
TM 
system. At first, SPR chip has been modified with OspC Borrelia antigen, which capture the 
anti-Borrelia antibodies. Successful adsorption of the OspC antigen on the surface could be 
seen as 23 AU increase in the signal. After a washing step using PBS buffer, blocking of the 
surface was conducted using BSA; no detected signal was obtained; this indicates to the 
absence of free binding sites on the surface. The immobilized amount of antigen was 
sufficient to cover the surface. Therewith, the OspC antigen could capture the antibodies 
from the serum, which appear as increasing in the signal with 10 AU after serum loading. 
Finally, interaction of protein A with the antibodies could be observed; 15 AU as a signal 
indicates the capture of nanoparticles on the surface (Figure 30). The binding is caused by a 
specific interaction of antibodies with protein A; this can be confirmed when nanoparticles, 
which has been totally blocked with BSA, was injected as a control after the positive serum. 
Using the same setup, only 2 AU as increased signal could be obtained (Figure 31). In 
conclusion, functionalization of AuNPs with protein A was successful, producing an 
applicable label for the ABICAP
TM
 system. 
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Figure 30 High affinity response of AuNPs modified with protein A to antibodies on SPR 
chip. Antibodies in human serum sample were attached to the surface due to a specific 
interaction with OspC Borrelia antigen. Antigen has been hydrophobically adsorbed to SPR 
chip. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 31 Weak affinity of AuNPs blocked with BSA to antibodies on SPR chip. Antibodies in 
human serum sample were attached on the surface due to a specific interaction with OspC 
Borrelia antigen. Antigen has been hydrophobically adsorbed to SPR chip. 
Results 
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5.5.3 Detection using AuNPs modified with protein A 
A second approach based on AuNPs integrated with the hydrophobically modified 3-DPESB 
was developed. The addition of the AuNPs modified with protein A after serum application 
allowed direct and convenient differentiation between positive and negative sera. In addition, 
loading silver enhancer solution after AuNPs could enhance the signal two times. AuNPs are 
able to reduce the silver ions on its surface to elementary silver, giving a strong absorption of 
visible light that in turn would improve the assay sensitivity.  
Firstly, assay conditions were optimized using silver enhancer solution; one positive and one 
negative sera sample were used and results are summarized in Table 3.  
 
AuNPs Dilution 
 
 
Serum sample 
 
Antigen (VlsE) 
 
 
Optical density 
 
 
Standard deviation 
 
     
5 fold Positive 3 μg / sinter body 0.436 0.004 
5 fold Negative 3 μg / sinter body 0.163 0.076 
5 fold Positive 5 μg / sinter body 0.577 0.069 
5 fold Negative 5 μg / sinter body 0.288 0.049 
10 fold Positive 3 μg / sinter body 0.21 0.021 
10 fold Negative 3 μg / sinter body -0.018 0.019 
10 fold Positive 5 μg / sinter body 0.47 0.089 
10 fold Negative 5 μg / sinter body 0.041 0.012 
 
Table 3 Optical densities obtained after testing different dilutions of colloidal gold 
suspension and different concentrations of the immobilized VlsE antigen (3 and 5 μg / sinter 
body). One positive and one negative sera sample were used. Experiments 7 and 8 gave best 
results, 10-fold dilution of colloidal gold suspension and 5 μg VlsE for each sinter body 
(n=3). 
 
Best conditions were found with a 10 -fold diluted AuNPs suspension and a VIsE 
concentration of 0.5 µg per sinter body. For the positive serum, an optical density of 0.47 ± 
0.089 (n=3) was observed, where as the negative serum gave 0.041 ± 0.012.  
This means that the optical density of the negative serum is 10-fold lower than that of the 
positive serum. 2 more positive and 2 more negative sera sample were then tested using the 
optimized conditions; results are summarized with the corresponding 3-DPESB in Figure 32. 
Results 
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3-DPESB loaded with positive samples display with reddish grey color, which produced as a 
result of silver ions reduction on AuNPs surface. Whereas, 3-DPESB loaded with negative 
samples did not show any change in color. This significant difference allows the 
differentiation between positive and negative sera. In general, the background was found to 
be very low and the cut off level is at about 0.05, which is also very low. Differences between 
positive and negative sera are significant with analysis time 12 min. 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
Figure 32 (a) color development of 3 positive (left) and 3 negative sera (right) after detection 
with silver enhancer and (b) optical densities of the related sera samples after detection with 
silver enhancer at 650 nm (n=3). 
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As alternative, absorbance intensities were measured directly after loading AuNP at 650 with 
exclusion of silver enhancer. The previously optimized conditions have been utilized; the 
direct detection of AuNPs resulted in lower signal intensity than the ones obtained from 
metallic silver. Optical density of 0.21 was acquired for a positive sample, in contrast to 0.47 
when silver enhancer solution was added. However, as a huge advantage, direct detection of 
AuNPs results can be visibly observed exclusively after 5 min with convenient differentiation 
between positive and negative samples (Figure 33). More investigation could, however, 
enhance the signal in the same analysis time (5 min); this might be established with 
employing bigger nanoparticles or quantum dots for detection.  
 
 
 
 
 
 
  
 
 
Figure 33 (a) optical densities of the related sera samples after detection with gold 
nanoparticles at 650 nm (n=3), and (b) color development of one positive (left) and one 
negative sera (right) after detection with gold nanoparticles.  
 
5.6 Serological diagnosis using covalently modified 3-DPESB  
Adsorptive immobilization of proteins on a hydrophobic surface is a convenient method. 
However, covalent immobilization provides more organized biomolecules layer; in effect, it 
would lower the steric hindrance effect, providing more sensitive and reproducible test.  
Results 
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Therefore, a covalent immobilization technique has been developed for the 3-DPESB 
modification. Polyethylene is rather resistant to most chemicals; therefore, its surface 
activation needs harsh and well-controlled conditions. In the here presented approach, 
hydroxyl groups were introduced to the 3-DPESB by UV photo grafting of 2-propenol at 254 
nm over 6 h. Subsequently, N, N´-disuccinimidyl carbonate was used for hydroxyl-group 
activation. Finally, the VlsE antigen could be immobilized through free amino groups. In a 
final step, free binding sites have to be blocked by different reagents.  
Different concentrations of the VlsE antigen, different concentrations of blocking reagents 
and different dilutions of serum sample have been tested to obtain the assay optimum 
performance. Best conditions were found at: 0.5 μg of immobilized VlsE antigen per sinter 
body, 40 mM ethanolamine for inactivation of active carbamate groups (for 35 min 
incubation), 0.5 % BSA + 5 % sucrose in PBS for blocking free binding sites (for 75 min 
incubation), and 500-fold serum dilution. 
Again, HRP labeled secondary antibodies was used for detection. Employing the previously 
mentioned optimized conditions, positive and negative sera sample were examined; obtained 
optical densities with corresponding color development on the 3-DPESB are shown in Figure 
34. Positive samples display with blue color, confirming the presence of the infecting agent. 
Negative samples display with colorless 3-DPESB. Difference between positive and negative 
sera can be considered significant. The cut off value for positive sera can be placed at optical 
densities between 0.15 and 0.2. Nevertheless, lower signal intensities were obtained in 
comparison to signal intensities obtained using the 3-DPESB modified with hydrophobic 
adsorption. 
A second label, nanoparticles based on Sudan IV, was tested.  Sudan IV is a synthetic dye; it 
has a maximum absorbance at 520 nm and displays with red color.  Using the same assay 
optimized conditions, different dilutions of nanoparticle suspension were tested, 200, 133, 
100, and 50-fold dilution. This step aimed to achieve the most sensitive and specific 
performance of the assay. 200-fold and 50-fold dilutions resulted in no significant difference 
between positive and negative samples. When 100 and 133 fold dilutions were tested, 
differentiation could be possible. Yet, the differences between positive and negative sera are 
rather low and could not be considered. More investigations are required to employ such 
nanoparticles on the proposed system. Depending on the solution, the cut off value has to be 
set between 0.2 and 0.3 (Figures 35 and 36). 
Results 
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Figure 34 (a) color development of 5 positive (upper row) and 5 negative (lower row) sera, 
and (b) related optical densities after performing the assay on covalently modified 3-DPESB. 
Detection was performed using HRP labeled secondary antibody and optical densities were 
measured at 650 nm (n=3). 
 
b 
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Figure 35 (a) color development of 5 positive (upper row) and 5 negative (lower row) sera, 
and (b) related optical densities after performing the assay with streptavidin/Sudan IV/HRP 
nanoparticles in 100-fold dilution on covalently modified 3-DPESB. Detection of the blue 
TMB precipitate was conducted at 650 nm (n=3). 
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Figure 36 (a) color development of 5 positive (upper row) and 5 negative (lower row) sera, 
and (b) related optical densities after performing the assay with streptavidin/Sudan IV/HRP 
nanoparticles in 133-fold dilution on covalently modified 3-DPESB. Detection of the blue 
TMB precipitate was conducted at 650 nm (n=3). 
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5.7 Serological diagnosis using two-antigen modified gold nanoparticles 
A second platform was proposed for rapid serological analysis; the developed method mainly 
employs AuNPs modified with two antigens, VlsE antigen and protein A, for diagnosis. To 
verify the test feasibility, three different sizes of AuNPs were synthesized and investigated. 
Synthesized nanoparticles showed maximum absorbance at 524, 527.5, and 531 nm, which 
are similar with previously reported absorbance measurements of AuNPs with average 
diameter around 20, 30, and 40 nm, respectively (Figure 37).  
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 37 UV-vis spectra of synthesized gold nanoparticles. 3 different sized have been 
synthesized, 20 nm AuNPs with maximum absorbance at 524 nm (a), 30 nm AuNPs with 
maximum absorbance at 527.5 nm (b), and 40 nm AuNPs with maximum absorbance at 531 
nm (c).  
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To modify the synthesized nanoparticles, covalent immobilization of the two antigens was 
utilized. Gold nanoparticles was capped with carboxyl groups using MUA at a first step (86). 
Then an EDC/NHS coupling reaction was pursued (109), which resulted in the attachment of 
antigens to the carboxyl groups on surface.  
One positive serum and one negative serum were tested to confirm the feasibility of modified 
AuNPs as well as to optimize the assay conditions.  
To select an optimal pH for the test, 50 mM phosphate buffer pH, 6.5, 7.4, and 8.7, were used 
to perform the assay. The different pH values, 6.5, 7.4, and 8.7, were examined based on the 
fact that the maximum equilibrium constant of antibody-antigen interaction in solution can be 
obtained between pH 6.4 and pH 8.7 (110, 111). AuNPs and serum sample were incubated in 
the buffer with the desired pH. UV-vis spectra were then recorded.  
When phosphate buffer pH 7.4 was used, significant difference in absorbance between 
AuNPs incubated with positive sample and AuNPs incubated with negative sample was 
observed. The difference, as explained, is due to aggregation of AuNPs because of 
compatible antibodies found in positive serum.  
UV-vis spectra were recorded after 3 h incubation. A red shift, 4 nm, in the maximum 
absorbance and broadening in the absorbance band in the region between 550-680 nm of 
AuNPs incubated with positive sample was seen as expected; on the other hand, no 
significant difference could be observed when pH 6.5 or pH 8.7 was used (Figure 38). The 
absorbance band in the region between 550-680 nm of AuNPs incubated with positive and 
negative were similar. This shows that there was no aggregation when positive serum was 
tested. PBS buffer pH 7.4 has been used further for all optimization steps. 
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Figure 38 Normalized UV-vis spectra of 20 nm AuNPs after 3 h incubation with positive 
serum (black) and negative serum (red). Spectra show the behavior of modified AuNPs at 
different pH values, 7.4 (a), 6.5 (b) and 8.7 (c). 50 mM phosphate buffer was used. 
 
Additives such as salt speed the protein interaction in solution. In the here case, effect of 
ionic strength was investigated on the assay incubation time. 50 mM and 100 mM NaCl were 
added to the phosphate buffer. Using the prepared buffers, 3 h incubation was necessary also 
to observe a difference in color. It seems that increasing salt concentration had no effect on 
the proteins interaction (Figure 39).  
Moreover the aggregation of AuNPs caused by the positive sample was rather low when 50 
mM NaCl was used; besides, 100 mM NaCl hindered and prevented the protein interaction 
(positive serum showed no effect on the AuNPs).  
50 and 100 mM NaCl could be considered very high concentrations, which lower the affinity 
between proteins; or else the interaction between proteins seems to be less dependent on 
those high salt concentrations (112). 
Results 
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Figure 39 Normalized UV-vis spectra of 20 nm AuNPs after 3 h incubation with positive 
serum (black) and negative serum (red). Spectra show the behavior of modified AuNPs at 
different NaCl concentrations, 0 mM (a), 50 mM (b) and 100 mM (c). 50 mM phosphate 
buffer was used. 
25-fold dilution of serum sample was used in the previous experiments. At this dilution, 
maximum absorbance intensity at 590 nm was measured when AuNPs were incubated with 
the positive sample. A calibration curve was needed in order to evaluate the test sensitivity; 
so absorbance intensities were recorded to different dilutions of a positive sample at 590 nm 
(Figure 40). At higher serum concentration, higher aggregation of nanoparticles was detected, 
which appeared as increasing in the absorbance intensities.  
A good linear range could be obtained between 25 and 60-fold dilution with R-squared = 
0.96144. Higher dilution (120-fold dilution) resulted in very low signal, which could not be 
considered for the calibration. 80-fold dilution as a limit of detection was calculated for the 
presented assay. The sensitivity seems to be low and developed ELISA assay showed better 
sensitivity (113). However, the sensitivity of such platform could be considered convenient. 
More investigations could, however, improve the sensitivity further.  
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Figure 40 Plot of absorbance intensities of modified 20 nm AuNPs at 590 nm after 3 h 
incubation with different dilutions of positive serum. Linear range obtained between 25-60 
fold dilutions with R-squared = 0.96144. Higher dilution (120-fold) resulted in very low 
signal, which could not be considered. 
The main objective of the presented work was to develop a colorimetric test valid for point of 
care testing; that means a clear difference should be easily observed using naked eyes. The 
previous experiments showed a slight difference in color between positive and negative 
samples. Therefore bigger AuNPs sizes, 30 nm and 40 nm, were further tested as a trial to 
enhance the proteins interaction. Modified 30 nm AuNPs showed very promising results. 
Aggregation of AuNPs caused by positive samples could be easily observed using naked 
eyes. In addition, negative sample had no visible effect on AuNPs. 30 min incubation and 
phosphate buffer with 50 mM NaCl were necessary in the here case. Visual observation of 
AuNPs confirms the accumulation of particles to each other after incubation with positive 
samples; this could be due to the specific interactions to antibodies (Figure 41a).  
UV-vis spectra showed also very low absorbance intensity and broadening of absorption 
band in the absorption region between 550 nm-680 nm of AuNPs that incubated with positive 
serum (Figure 41b). The shorter time could be due to the bigger size that enabled faster 
access to antibodies. This assumption was confirmed when 40 nm AuNPs was aggregated 
because of positive serum after 1 min. 
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Figure 41 (a) color development of 30 nm AuNPs after 30 min incubation with two positive 
sera (left) and two negative sera (right), and (b) normalized UV-spectra of 30 nm AuNPs 
incubated with one positive (black) and one negative (red) sera samples (b). 
Modified 40 nm AuNPs showed shifting in maximum absorption (25 nm) and broadening in 
the absorption band in the absorption region between 550 nm-680 nm when incubated with 
positive serum after only 1 min (Figure 42).  
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A significant difference between the positive and negative samples can be recorded using 
spectrometry measurements, however, a slight difference was visible using naked eyes.  
 
 
 
 
 
 
 
 
 
 
Figure 42 Normalized UV-vis spectra of 40 nm AuNPs incubated with positive sample 
(black) and negative serum (red). Spectra recorded after 1 min incubation. 
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6 Discussion 
Serologic tests developed to detect antibodies directed to borrelia burgdurferi come mainly 
as a confirmation of the disease. Serologic diagnosis, as recommended, should be performed 
using a two-tiered testing in order to avoid the false positive results that caused by the cross-
reaction with other spirochete infections (61). A first test should employ a sensitive enzyme 
immune assay for screening, followed by a western blot test for confirmation. Two-tiered 
testing is highly specific (95%-100%) and highly sensitive (>90%) in late stages of Lyme 
disease (114). As a drawback, it has low sensitivity in the early acute phase of the disease; 
besides, it is time consuming and labor intensive. Many studies have been focusing on 
developing alternatives to the two-tiered testing, which should be more rapid as well as they 
should be more specific in the early stage of the Lyme disease. Alternatives could be 
established in one-tier manner that are principally based on using highly specific recombinant 
antigens or synthetic peptides for antibodies detection. Such antigens offer the high specific 
detection of disease even in early stages; also they show low cross-reaction with other 
spirochete infections.  
Bacon, et.al, developed a one-tier testing that is equal or exceed the performance of the two-
tiered testing for detecting antibodies directed to borrelia burgdorferi (115). The assay is 
based on measuring IgG antibodies directed to, recombinant VlsE antigen (rVlsE1), a 10-mer 
conserved portion of OspC (pepC10), or a synthetic peptide C6 region of VlsE antigen. It was 
performed on ELISA microtiter plates and results revealed that the assay is simpler and more 
readily standardized than two-tiered analysis. The assay showed high specificity for detecting 
antibodies (99%) for the recombinant VlsE antigen and for the synthetic peptide C6.  
Likewise, immunoblot assay could be performed based on using recombinant antigens of 
Borrelia burgdorferi, Borrelia afzelii and Borrelia garinii such as p100, VlsE, p39, OspA, 
OspC, p41. The test showed promising results and could be used as alternative to the two-
tiered testing (116).  
A second approach has been developed, which is based on using a multiplex assay technique; 
it showed also better results than two-tiered testing. Porwancher, et.al, developed a new 
multiplex immunoassay for detection of both VlsE1-IgG and pepC10-IgM antibodies 
simultaneously using the AtheNA Multi-Lyte test in a multiplex system (117). The test is a 
sandwich immunoassay based on flow cytometric separation of fluorescent micropaticles by 
use of Luminex xMAP technology (118); where the recombinant antigens are  covalently 
bound to the microparticles before performing the test. The test showed specificity 95-100% 
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for the recombinant VlsE antigen. The multiplex technique can perform multiple antibody 
assays with the same serum sample. The technique, in addition, is able to distinguish up to 
100 separate reactions in a single run.  
A third approach can be considered also was developed based on a fully automated random-
access Liaison analyzer, which employs two-step chemiluminescence immunoassay 
technology for Lyme borreliosis diagnosis (99). The operation of Liaison analyzer is 
straightforward, flexible and can be used as alternative to conventional immunoassays. The 
test showed overall specificity for the recombinant VlsE antigen (98%) and for the peptide 
C6 (97.8%).  
 
Yet the abovementioned assays, which are considered most recent and most common 
approaches for diagnosis of Lyme disease, are time-consuming need lot of incubation steps 
and are not suitable for rapid point of care testing (100). For example, the multiplex based 
test needs several steps including mixing using shaker, vortexing and sonication as well as 
the several long incubation times of reagents (30 min each). In addition, the covalent 
immobilization of antigen on microparticles is needed before conducting the assay. The 
microtiter ELISA based assays and immunoblot assays need long incubation time to provide 
the results, 12- 24 hours. The Liasion Borrelia test is advantageous over others in terms of 
assay time; the test can be performed in 60 min; yet the analyzer needs well-trained personnel 
to perform the test and interpret the results.  
All the abovementioned alternatives are performed in a stationary manner, which in turn 
require large volume of the sample as well as high concentration of the analyte. This is 
considered unfavorable in case of studies with limited sample volume or when the sample 
needs to be further tested.  For example, ELISA on microtiter plates applies serum with 
dilution 1:100, multiplex assays require serum with dilution 1:21, immunoblot assays load 
serum with dilution 1:200, and the Liasion test requires serum with dilution 1:100.  
In our investigations, new assays based on one-tier testing could be developed with high 
selectivity behavior for diagnosis of Lyme disease. This returns to the used recombinant VlsE 
antigen and the synthetic peptide C6 region of VlsE antigen, which induce a strong and 
specific antibody response that can be detected from early to late phase during the disease in 
humans infected with Borrelia burgdorferi or with European genospecies including Borrelia 
afzelli and Borrelia garlnii. Simultaneous, they show low cross-reaction with the other non-
pathogenic Borrelia strains.  
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In our work, VlsE and C6 antigens could be utilized, enabling the specific recognition of anti-
Borrelia-antibodies in shorter analysis time and more sensitive manner than ELISA, 
immunoblot, multiplex-based assays, and chemiluminescence Liaison analyzer based assays. 
Our developed assays take around 5 to 30 min to obtain the results. They are easy to handle 
and cost effective. Besides, they are very rapid and suitable for point of care testing. 
Developed immunoassays are considered superior over the conventional methods in terms of 
analysis time, sensitivity, and the very small volume of the sample.  
The main element in our development was to employ new platforms, on which the interaction 
should be conducted. 3-DPESB with dimension of 2 × 2.5 mm could be used as the first 
platform in an immune affinity flow system based on a little disposable plastic column 
(ABICAP
TM
) (119). ABICAP
TM
 based assays are advantageous in terms of rapidity, easiness 
and specificity. The flow of reagents through the column, which depends mainly on gravity, 
is advantageous because incubation steps can be eliminated, reducing the nonspecific 
interaction and shortening the test time. In addition, large sample volumes can be applied 
when needed, providing an increased sensitivity by means of enrichment of the analyte 
through immune separation. A visible detection of analyte is also likely, allowing 
colorimetric point of care testing.  
VlsE and C6 antigens could be easily immobilized on 3-DPESB surface. The used 
immobilization techniques provide the long storage time of the antigen-modified platform at 
4 °C. Hereby, the assay starts by applying the serum sample and any prior steps are 
unnecessary; this is superior over the conventional methods in terms of the quick and easy 
performance. The 3-DPESB can be either placed in a miniaturized cartridge as used in the 
here presented investigation or alternatively placed in a pipette tip (‗Dia Tip‘). In the latter 
case, a programmable electronic pipette or a pipette robot is required. Further on, required 
instrumentation (pipette, simple hand-held photometer with one or two wave length) is 
simple and inexpensive so that this assay format is suitable for POC diagnostics even under 
difficult conditions in developing countries. 
Our results showed that, VlsE-modified 3-DPESB coupled with HRP labeled antibody as a 
label offered very high sensitivity for detecting antibodies directed to Borrelia in human sera 
samples, particularly when hydrophobic adsorption of VlsE was used. This approach offered 
the highest sensitivity among our developed approaches. The hydrophobic immobilization 
seems to be very promising with such 3-D structural; it seems to preserve the antigen 
structure and activity, providing a maximum performance. The overall performance of the 
assay seems to be superior. Antibodies could be detected in 1000-fold dilution of sera 
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samples with very short time for the entire analysis (20 min). Also the limit of detection can 
reach 2000-3000 -fold serum dilutions.  
For 16 of the 17 positive sera there is a clear differentiation from the negative sera in addition 
there was no false positive out of 20 negative samples (Section 5.5.1). There is only a 
problem with sample 11, which is false negative. The reason for this needs further 
investigation. It might be possible that the Borrelia infection represented by this serum is 
atypical or the VIsE antigen on the Borrelia cell wall shows some modifications leading to 
antibody production which cannot be detected by the used recombinant VIsE antigen. 
Therefore it can be recommended to use at least one further antigen structure like the Decorin 
binding protein A (DbpA), outer surface protein C (OspC) or the Borrelia membrane Protein 
A (BMPA) for safe detection.  
Results showed also when VlsE covalently immobilized on 3-DPESB surface, detection of 
antibodies using HRP labeled antibody was possible in 500-fold serum dilution with analysis 
time 20 min. Taking into account that higher amounts of VIsE antigen were necessary for 
covalent immobilization and the dilution of the serum sample was lower, there seems to be 
no overall advantage of covalent immobilization in the assay performance. Nevertheless, the 
assay seems to be promising and showed better results than the conventional serologic tests; 
the difference between negative and positive sera is significant. It can be suggested that the 
storage properties of the covalently modified 3-DPESB are better.  
From results it is clear that lower signal intensities were obtained comparing to the 3-DPESB 
hydrophobically modified with VlsE (Section 5.6). The reason could be due to a loss in the 
antigen activity, which could be caused by the used coupling method. The antigen could be 
immobilized through more than one functional group; this could cause a conformation in the 
antigen‘s active region and loss of its activity.  
A highly sensitive and selective detection of anti-borellia antibodies could be accomplished 
using HRP labeled secondary antibody. A blue TMB-precipitate was produced when 
Borreliosis-positive sera were applied. The antigens could recognize anti-Borrelia antibodies 
in serum sample; in effect HRP labeled antibody could be attached to the surface when 
loaded, enabling afterwards the oxidation of the TMB solution. This resulted in producing a 
blue precipitate, which can be detected at 650 nm. On the other hand, only little coloration 
was visible when negative sera were tested, suggesting the absence of the anti-Borrelia 
antibodies from samples. Using alternative labels like fluorescence should increase sensitivity 
even further. 
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In our work we were able to perform the serologic test only in 5 min with good specificity, 
which is considered as a huge advantage. VlsE-modified 3-DPESB coupled with AuNPs as a 
label provides a specific detection of antibodies in 250-fold dilution of serum sample in 5 
min. The obtained signals are not considered high but the specific detection could be 
considered significant, particularly after the visible observation of both positive and negative 
samples. A clear difference can be seen using only naked eyes (Section 5.5.3). AuNPs 
display a reddish color so that direct detection of AuNPs absorbance at 520 nm should be 
possible. However, with the used photometer optical density was too low. In contrast 
detection at 650 nm gave better results. This might be caused by the structure of the used 
polyethylene, which is not transparent but opaque. It could be also due to aggregation of 
AuNPs on the 3-DPESB surface; the aggregation in turn caused a shift in the AuNPs 
absorbance to higher wavelength, at the region between 600 and 680 nm. Thus, results could 
be recorded with higher intensities at 650 nm. Adhesive AuNPs on 3-DPESB could be seen 
as a light red color when positive sample was tested. This could be attributed to the specific 
interaction of AuNPs with the recognized antibodies. In contrast, the final washing step could 
remove all AuNPs from the column, leaving a colorless 3-DPESB when negative sample was 
tested; this in turn confirmed the lacking of the antibody-antigen interaction. Signal might be 
further enhanced with the same analysis time if bigger nanoparticles or quantum dots would 
be used; this should be further investigated.  
Additional advantage when using AuNPs as a label is the ability of AuNPs to catalyze the 
reduction of silver ions to elementary silver, giving a strong absorption of visible light. 
Results showed that detection of metallic silver produced after applying a silver enhancer 
solution improved the test sensitivity with analysis time only 12 min.  As advantage of 
detecting gold nanoparticles or elementary silver, background was found to be very low; 
somehow, AuNPs enhance the specific interaction of the immobilized protein A with the 
detected antibodies. The reason could be due to the big size of AuNPs compared to 
conventional labeled proteins. The big size of AuNPs seems to overcome the weak unspecific 
interaction, moving all unbound AuNPs with the washing buffer out of the system.  
 
As an interesting alternative, nanoparticles consisting out of Sudan IV, streptavidin, and HRP 
were used for detection. Sudan IV is a synthetic dye that displays with red color.  It has an 
absorbance at 520 nm. TMB substrate can be oxidized by HRP on the nanoparticle surface 
giving a blue precipitate with absorption at 650 nm. In effect, these nanoparticles allows a 
simultaneous detection at two different wavelengths. This can be achieved using ABICAP
TM
 
Discussion 
 82 
photometer, which facilitates the measurements at two wavelengths, 520 and 650 nm.  Yet, 
Sudan IV particles absorption at 520 nm was too low for detection; only the blue TMB 
precipitate could be evaluated at 650 nm. Results showed that detection using such 
nanoparticles was not beneficial in our system. Very high background was observed, which 
limited further testing of the nanoparticles (Section 5.6). The reason for the high background 
could be related to the functionalization method of the nanoparticles. Hydrophobic adsorption 
of biomolecules was conducted; a protective layer of bovine serum albumin was adsorbed at 
a first place on Sudan IV particles, then HRP enzyme and anti-human biotin antibody were 
immobilized by hydrophobic manner. The affinity of BSA to the fat-soluble dye, Sudan IV, 
might not be strong enough to preserve BSA on the surface. BSA could be washed away by 
buffer solutions, exposing the particles surface. Thus non-specific interaction of nanoparticles 
to the surface might be occurred. In summary, the use of the multi-functional 
streptavidin/Sudan IV/HRP did not give any advantage. In theory, simultaneous detection of 
the Sudan IV at 520 nm and the polymerized TMB at 650 nm should be possible, but failed 
with the used real human samples. 
In our work we showed also a development of a second approach, which is based also on 
ABICAP
TM
 technology; the proposed approach utilize the high specific interaction between 
the ConA lectin and the mannan polysaccharides. A fusion protein containing the antigen C6 
part and the ConA part could be immobilized by self-organization on 3-DPESB surface 
modified with mannan; this resulted in a good accessibility of the Borrelia C6 antigen. In 
consequence testing human sera samples was performed in a simple and convenient 
ABICAP
TM
 format, allowing POC diagnosis. Results revealed that the fusion protein with C6 
antigen part produced in our group showed similar specificity like the commercially available 
recombinant VlsE antigen. The test takes 20 min only and detection using HRP labeled 
antibody offered also excellent sensitivity; 1000-fold dilution of sera could be tested with 
high specific interaction (Section 5.4). Employing mannan modified 3-DPESB and a fusion 
protein is considered generic because a huge variety of protein structures can be linked to the 
ConA moiety in a similar manner as here presented. Outer protein sequences of pathogenic 
bacteria and viruses (like Zika virus) can be easily fused to the ConA moiety and a 
serological assay on the here presented platform can be established within a couple of weeks. 
This is of huge importance in case of an unexpected outbreak like Ebola in 2014 and Zika in 
2015. As a further advantage of the method, the protein component is added shortly before 
the assay is started. Storage conditions can be specifically adapted to the need of the 3-
DPESB and the fusion protein separately. 
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The ABICAP
TM
 technology has been used in the development of some immunoassays, e.g. 
the rapid diagnosis of Ebola virus infection (120) and the detection of Yersinia pestis (121). 
Yet, the used platform (3-DPESB) in the here investigations is smaller in size, which has not 
been previously studied. The small size would provide a cost effective and more rapid assay 
due to the lower amounts of proteins that are required to establish the assay. Polyethylene has 
been proposed as a convenient and inexpensive carrier in integration with the ABICAP
TM 
technology. Granular material can be easily brought in different shapes, even with complex 
geometry. For our investigations, small porous cylinders with a diameter of 2.5 mm were 
chosen for the immunoassay. A porous polyethylene surface enables a smooth flow of the 
sample even with whole blood. Moreover, the large surface area allows high stable 
immobilization of proteins even by hydrophobic interactions. 
As a disadvantage, covalent immobilization of biomolecules on polyethylene surface is only 
possible after surface activation. However, electromagnetic waves, plasma and highly 
reactive gases like ozone can be used to accomplish the surface activation. The activation of 
polyethylene has been easily achieved in our work using UV irradiation. The UV irradiation 
enabled, in addition, the activation of the inner surface of the small 3-DPESB over several 
hours, which has been proved by staining experiments. In effect, sufficient amounts of 
biomolecules can be immobilized, which enhance the test sensitivity further. 
 
Our results showed the potential to develop a third approach that showed promising results 
and can be used as alternative to the conventional serologic tests. This approach employed 
AuNPs successfully to carry antigens; simultaneously it acted as a label for detection. As 
reported in literature (122), color of two gold nanoparticles shift to blue when the distance 
between them is less or equal to the diameter of the gold nanoparticle itself. The reason for 
that is the coupling of plasmon fields of the adjacent particles.  This results in changing the 
frequency of the oscillated conduction electrons. Consequently, gold nanoparticles would 
maximally absorb light at higher wavelength, which appear as a blue color (123).  This 
phenomenon (aggregation of gold) was successfully utilized in our experiments to detect 
anti-Borrelia antibodies in human sera samples.  
Results indicate that AuNPs modified with VlsE and protein A showed very specific style to 
detect antibodies directed to Borrelia. The assay can be performed in 30 min in a 
homogeneous one-step assay (Section 5.7). A clear distinguish between positive and negative 
samples can be observed using only naked eyes. Also, measurement of absorbance intensity 
at 590 nm of AuNPs after a test is able to provide the necessary data for quantitative analysis.  
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20-fold serum dilution was used in the proposed assay. The test is not highly sensitive; 
however, the simple performance of the test in one-step manner is considered very 
advantageous. The reason for the low sensitivity might be due to the immobilization step, 
which lack the full coverage and proper organization of proteins on the AuNPs surface. 
Employing another immobilization technique could result in better sensitivity. This study was 
to verify the hypothesis of employing the aggregation of AuNPs phenomenon caused by 
specific interaction to detect antibodies in sera sample. Thus, more investigations are 
believed would improve the test sensitivity and performance further.  
Results showed that UV-vis spectra of 20, 30 and 40 nm AuNPs confirmed the aggregation 
of particles, which incubated with the positive sample. Also from results we can confirm that 
the size of AuNPs has a crucial consequence on both assay time as well as assay sensitivity. 
Big AuNPs sizes (such as 30 and 40 nm) enabled faster access of immobilized antigens to 
antibodies, shortening the test time. 30 min was needed with 30 nm AuNPs to obtain 
convenient results and only 1 min with the 40 nm AuNPs; on contrary, 3 hours incubation of 
sample was needed when 20 nm AuNPs was used. The enhancement in the colorimetric 
detection caused by the bigger particle sizes could be due to the fact that color of two gold 
nanoparticles shifts maximally to blue when the distance between them is less or equal to the 
diameter of the gold nanoparticle itself (122). Based on that, the length of the immune 
complex (VlsE-Antibody-Protein A) produced between two particles might be above 20 nm. 
Therefore, the aggregation could be easily seen when bigger particle sizes were tested. 
Spectroscopy measurements are beneficial, however one main concern of the present work 
was to offer a rapid colorimetric point of care test. Thus prompt detection; particularly using 
naked eyes should be approached. A change in color from red to blue (caused by positive 
sample) was observed when 20 and 40 nm particles were tested; however, it could not be 
considered for a colorimetric detection. Only 30 nm AuNPs could undergo physical changes 
that can be clearly observed using naked eyes after aggregation. 30 nm AuNPs accumulated 
together forming a cloud like structure; the structure could appear with a blue shift in color 
(Section 5.7). This can explain the very low optical density obtained when 30 nm AuNPs 
incubated with positive sample; AuNPs was not distributed in solution rather than 
precipitated, so the incident light could interact only with few amount of particles. 
Although results could be obtained after only one minute using the 40 nm AuNPs, which 
consider a huge and pioneer advantage, main disadvantage limited working with 40 nm size 
was the aggregation of AuNPs caused by negative serum. It is believed that aggregation 
caused by negative sample, which took place after 5-10 minutes, was raised form unspecific 
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interactions. It seems like that the amount of immobilized antigens were not enough to cover 
the surface of AuNPs. As a result unspecific interaction was observed as aggregation with the 
negative sample. More investigations are required to improve the performance of this size. In 
general, the assay is very simple and easy to handle; applying the serum sample to the AuNPs 
mainly performs the assay with no additional steps. Aggregation of gold nanoparticles was 
mainly and successfully utilized for antibodies recognition in real sera samples. The high 
affinity of both protein A and antigen to a target antibody could be generally suggested in 
developing other line assays.  
 
6.1 Mannan-modified 3-DPESB platform 
As a first approach, 3-DPESB surface was modified with mannan polysaccharide, which 
served as the platform to capture a fusion protein with the C6 region of VlsE antigen. 
Mannan is a very hydrophilic molecule; its hydrophobic immobilization on polyethylene 
surface is not favorable. Therefore, primary functionalization of the 3-DPESB was necessary 
for a covalent immobilization procedure.  
Results showed that one-step UV photografting method seems to be easy and suitable for 
activation of such 3-dimensional structures. UV irradiation has a unique ability to manipulate 
the polymer surface without any influence on the bulk properties. UV photografting of small 
allyl monomers was selected for surface activation. Ally monomers generally able to provide 
the polymer surface with functional groups. They form active radicals after interaction with 
light; the grafting of radicals can then be achieved on the polymer surface in presence of 
initiator. 2-propenol was successfully used here as a building block to establish the active 
surface. The allyl alcohol, 2-propenol, tends to form an active polymer layer on the 
polyethylene surface rather than forming a homopolymer, this is due to its low reaction rate 
of polymerization. The grafting of 2-propenol monomers, which lasted 6 h, was conducted in 
one-step grafting process; the benzophenone as initiator and 2-propenol were incubated and 
irradiated in the same solution. It is believed that benzophenone abstracted hydrogen from the 
polyethylene surface, providing a macro radical that can react easily with the 2-propenol 
radicals.  
The intensity of the absorption bands increases over time so that best results were achieved 
after 6h. The improved yield of grafting when irradiation time increased could be due to the 
low reaction rate of the 2-propenol; as a consequence, more monomers can be grafted with 
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time.  The low reaction rate, in addition, is supposed to provide the surface with a rather 
organized active layer (124, 125). Longer exposure times seem to be possible but will give 
some problems because of evaporation of solvent accompanied by bubble formation at 3-
DPESB surfaces. Therefore, longer reaction times than 6h are not recommended. Methanol as 
an organic solvent was used in the grafting process. Methanol showed inactivity toward UV 
light; unlike acetone, which was also tested and showed some activity and radical 
participating, leading to many difficulties in the grafting process.  
Amounts of both the photoinitiator and the monomer should be sufficient; with those 
amounts a new grafted layer can be obtained. Best results, which yield in covering the full 
sinter bodies, were found to be when the reaction mixture contained 3 % (w/v) of 
benzophenone and 25 % volume of 2-propenol. Volume ratios of 2-propenol like 1:1 or 
strongly diluted solutions like 5 % did not give any advantage in the obtained FTIR spectra. It 
is assumed that the ratio between the used benzophenone and the 2-propenol is of 
importance.  
Active hydroxyl groups, which enabled further immobilization steps, were introduced to the 
surface after a grafting step. Results showed that mannan could be attached to the activated 
surface through a monolayer with defined orientation (APTES). A densely packed monolayer 
of APTES was introduced, simply by dipping the polyethylene in an organic solvent 
containing the APTES. A condensation reaction takes place between the hydroxyl groups and 
the APTES molecules with the loss of ethanol and hydrolysis of alkoxy groups (126). This 
resulted in the covalent grafting of hydroxyl silane product on the surface and formation of 
aminopropyl silane film. Drying the 3-DPESB under high temperature is assumed to 
strengthen and densify the aminopropyl silane layers; horizontal polymerization (i.e., the 
formation of Si-O-Si bonds between adjacent surface aminopropyl silane molecules) is 
enhanced upon heating after the SAM is attached (127). The monolayer would aid to adopt 
the proteins in a more uniform orientation on the surface; this in turn enhanced the 
reproducibility and specificity of the assay, as can be seen when sera samples were tested 
(Section 5.4). It seems that the silane monolayer plays a key role in decreasing the non-
specific interaction in the presented assay. Using silane layer in the immobilization 
procedure, as has been previously reported, assures a highly specific interaction of proteins 
(128, 129).  
The APTES introduced amino groups all over the surface, which has been confirmed after a 
Bradford protein quantitation assay. The Bradford method has the advantages of being fast, 
simple, and highly sensitive. The method has been developed for protein quantitation based 
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on a reaction between basic amino acid residues and Coomassie brilliant blue G-250 in acidic 
solution. The reaction can be observed as a blue shift in the dye form. The absorbance 
intensity can be measured at 520-590 nm. The Bradford method could be utilized to confirm 
the presence of amino groups on the sinter body‘s surface after APTES grafting; sinter bodies 
modified with APTES could react with the Coomassie dye, causing a shift in the dye color, 
which can be seen as a dark blue.  The APTES grafting provided a homogenous distribution 
of amine groups on the surface, which could be observed as a fully coloration of the 3-
DPESB (Section 5.2). On the other hand, the unmodified 3-DPESB without any treatment 
(reference) display with a pale blue color. Based on the control experiments, it seems that the 
silanization grafting was successfully performed (Section 5.2).  
Mannan could react with the amine groups on surface and be immobilized via imide bond. 
However activation of mannan to carbamate intermediate was required prior to its 
immobilization. N, N`-disuccinimdyl carbonate, a highly reactive toward nucleophiles, could 
attack hydroxyl groups of the mannan in a nonaqueous solution, producing active 
intermediate that is able to react with amine groups on 3-DPESB surface and form cross-
linked product. The activated mannan (succinimidyl carbonate-mannan) was incubated in a 
final step with the silanized polyethylene, resulting in covalent binding of mannan to the 
surface.  All activation process has been performed in organic solvent since the DSC and the 
intermediate groups are susceptible to hydrolysis in aqueous solutions to form two molecules 
of NHS. 
In conclusion, it could be demonstrated that 3-dimensional polyethylene is a suitable carrier 
for immunoassays. As a disadvantage, UV radiation in combination with photografting takes 
a rather long time. The time can be probably reduced if direct oxidation of the polyethylene 
would be performed either with ozone or by plasma technologies. The here presented method 
seems to produce at least partially multilayers. This might influence the stability of 
immobilized mannan, but in practice there was no problem with this. The addition of the 
silane layer seems to stabilize the primary formed polyalcohol-layer. Obtained results 
demonstrate that i) the functionalization procedure summarized in Scheme 1 could be 
performed successfully. The successful immobilization of mannan could be observed after 
testing the sera sample with the help of the fusion protein. Mannan-modified polyethylene 
enabled a specific interaction with the recombinant fusion protein. Highest affinity between 
Con A and mannan could be achieved in presence of metal ions such as the transition metals 
and/or Ca
2+
 or Mg
2+
; thus the fusion protein was diluted in HEPES buffer containing calcium, 
manganese, and magnesium ions before it was applied to the surface. 
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6.2 Antigen-modified 3-DPESB platform 
A second approach based on employing 3-DPESB modified with VlsE antigen could be 
successfully developed for rapid analysis. Two different immobilization techniques 
(hyordophobic and covalent) have been well established for the 3-DPESB modification. 
Regardless the used immobilization method, it should be simple and reproducible; in 
addition, the immobilized proteins should be easily accessible and correctly oriented. In 
general, protein immobilization on surface of polymers such as polyethylene is controlled by 
many factors, e.g. the nature of the polymer, whether aliphatic or aromatic, the number of 
carbons of immobilized molecule, and the introduction of functional groups on the surface. 
Results revealed that with a special washing routine, VlsE could be easily adsorbed to the 
polyethylene surface. Hydrophobic adsorption is considered the easiest method for protein 
immobilization on polymer surface. The strong hydrophobic characteristic of polyethylene 
makes the physical adsorption of antigen rather easy. To achieve higher adsorption affinity of 
antigen, all immobilization steps have been conducted under vacuum; this in turn would 
remove any bubbles distributed inside the 3-DPESB, which may hinder the adsorption of 
antigen. Washing in 96 % ethanol, then washing with ethanol-water (50:50), and finally 
washing with the carbonate buffer enabled 3-DPESB to be easily functionalized with the 
VlsE Borrelia antigen. The washing steps were performed to eliminate any impurities, which 
could disturb the immobilization process. Besides, it aimed to adapt the 3-DPESB in 
carbonate buffer pH 9.6, in which the immobilization would take place. Carbonate buffer pH 
9.6 has been chosen based on a previously published study, which reported that carbonate 
buffer pH 9.6 yield the best conditions for hydrophobic immobilization (103). It is supposed 
that the hydrophobic parts of the antigen tend to exclude water molecules from solution and 
interact with the hydrocarbon chain of the polymer surface, causing the strong adsorption of 
antigen.  This in addition to the Wan Dar Waals forces and electrostatic interactions, which 
contribute and improve the protein immobilization process. Adsorptive immobilization of 
proteins on a hydrophobic surface is a convenient method and yielded in highly sensitive 
detection of antibodies in sera samples as shown in results.  
In our work we showed the potential to immobilize VlsE antigen on the 3-DPESB by 
covalent bonding as an alternative. This aimed to provide the surface with a rather organized 
biomolecules layer, which would lower the steric hindrance effect, providing more sensitive 
and reproducible test. Using the UV-photografting of 2-propenol, hydroxyl groups could be 
introduced and used to catch the VlsE antigen. Hydroxyl groups are not reactive toward the 
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protein functional groups such as free amine groups. Thus, hydroxyl groups have been firstly 
activated to DSC-activated hydroxylic compound after a reaction with N, N-disuccinimidyl 
carbonate (DSC) (102). The activation process has been performed in organic solvent since 
the DSC and the intermediate groups are susceptible to hydrolysis in aqueous solutions. The 
activated hydroxylic compound could then react with the free amine groups to form a 
carbamate bond, which display excellent stability. This resulted in fixing the antigen on the 
surface after a simple incubation step.  
Results showed also that, covalent immobilization required higher amounts of antigen on the 
surface than hydrophobic adsorption to establish a working assay. The reason might be due to 
the few free amine groups on antigen surface, which were used to couple the protein. 
Unlikely, hydrophobic adsorption utilized the long hydrophobic chain of the protein to 
interact with the polyethylene surface. As a result less amount of antigen was required to 
cover the surface. Using a ELISA like assay, the antibodies could be successfully recognized 
by the immobilized VlsE antigen. Both hydrophobic and covalent immobilization resulted in 
a surface, which is selective and sensitive toward detection of anti-Borrelia antibodies in 
human sera samples.  
In our work we showed also the successful modification of AuNPs with protein A by 
hydrophobic adsorption. The modification process provided AuNPs that enables a rapid and 
specific detection of antibody-antigen interaction in ABICAP
TM
 system. Hydrophobic 
modification of AuNPs depends mainly on the nature, pH, and concentration of the used 
buffer. It has a crucial impact on the stability and performance of AuNPs; irrelevant buffer 
would cause aggregation of AuNPs during immobilization, preventing protein adsorption.  
100 mM borate buffer pH 7.4 was found to be suitable for full coverage of AuNPs with 
protein A, which could be predicted when no aggregation was observed during 
immobilization (104); in contrast AuNPs aggregation was observed when phosphate buffer 
pH 7.4 as well as PBS buffer pH 7.4 were used for immobilization. 
SPR device could be employed to confirm the feasibility of the prepared AuNPs. The SPR 
C18 chip surface was efficient that enabled retaining the OspC antigen structure on the 
surface with maintained activity. OspC in turn caught antibodies from a positive serum 
sample. Subsequently, AuNPs modified with protein A could be tested. Results confirmed the 
successful modification of AuNPs with Protein A. More, AuNPs could be used successfully 
as a label for further experiment in the ABICAP
TM
 system as shown in results. 
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6.3 Two-protein modified AuNPs platform 
A third approach was developed based on employing two-antigen modified AuNPs for rapid 
analysis. AuNPs colloid that aggregates as a consequence of a positive sample addition could 
be successfully established. Simultaneously, the colloid remained stable with no alteration 
when a negative sample is being added. The two antigens (Borrelia VlsE antigen and protein 
A) have been immobilized on AuNPs surface; the antigens showed a specific interaction 
behavior to the target antibody found in sample, indicating the presence of an infection 
through the aggregation of gold nanoparticles. Turkevich method for AuNPs synthesis 
enabled the easy synthesis of three different sizes (20, 30, and 40 nm) of particles. The 
advantage of the method is the capability of controlling the AuNPs size easily by controlling 
the concentration of both gold (III) chloride hydrate and the trisodium citrate salt in the 
reaction solution.  
Most important step after AuNPs synthesis was to modify them with the chosen antigens; 
modification of AuNPs can be achieved using hydrophobic or covalent techniques. Covalent 
technique was chosen because, as previously mentioned, it enables a highly stable 
biomolecules bonding and allows a rather organized biomolecules layer, which would lower 
the steric hindrance effect, providing more sensitive and reproducible test. One common 
method, which we used, was to immobilize antigen through the free amino groups of lysine 
(or hydroxy) residues when considering the presence of carboxylate groups on gold surface. 
Hence, AuNPs was capped first with a self-assembled monolayer of 11-mercaptoundecanoic 
acid (MUA), which provided the surface with the carboxylate groups. MUA is a thiol acid 
mostly used to functionalize nanoparticles surface. The thiol end, which has strong affinity to 
gold, reacts with the gold surface, leaving a carboxyl group free and exposed for further 
immobilization. Then with a controlled pH solution, antigens could be immobilized using 
EDC/NHS coupling procedure. Concentration of MUA should be carefully optimized 
because high concentration of MUA would result in aggregation of gold nanoparticles.  
The aggregation takes place due to increasing hydrogen ions‘ concentration, decreasing the 
pH. For that, two factors were adjusted prior to AuNPs functionalization: i) increasing the pH 
of gold colloid using NaOH and ii) testing different concentrations of MUA. 4 μL of NaOH 
in 2 mL gold suspension had to be used before addition of MUA to prevent aggregation. 5 μL 
of 1mg mL
-1
 MUA (dissolved in ethanol) found to be a proper concentration; 
functionalization of gold nanoparticles was achieved with no observed aggregation.  
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From results it is believed that gold surface with carboxylate groups was activated after using 
a zero-length cross-linker EDC in presence of NHS. NHS prevents the hydrolysis of the EDC 
that tend to take place in the aqueous solution. Accordingly, an o-isoacyl urea intermediates 
was produced that can react with the free amine groups of antigens, resulting in a strong 
amide covalent bond dragging antigens to the surface (130). The performance of modified 
AuNPs can be verified as a red shift in the maximum absorbance as well as broadening of the 
absorbance band when incubated with positive serum. The AuNPs aggregation results in a 
visible change appear in the absorption region between 550 nm-680 nm. The change can be 
observed as a new peak (131); or else it can be observed as an increasing in absorption 
intensity, broadening of absorption band (132).  
Our results showed that broadening of absorption band rather than appearance of a new peak 
can be seen. One factor might play a key role in appearance of a new peak is the 
concentration of the analyte or the concentration of AuNPs. It could be that in our 
experiments the concentrations of either AuNPs or antigens were not sufficient to cause the 
appearance of a new peak around 550-680. So, broadening of absorption band in UV-vis 
measurements was taken as a confirmation of accumulation in the present work. Yet, visible 
observation was sufficient to distinguish between positive and negative samples.  
At first 20 nm AuNPs was used for assay conditions optimization because of their higher 
stability and lower sedimentation over the others. Optimum performance of AuNPs could be 
obtained when 10 μL 1 mg mL-1 VlsE and 12 μL 1 mg mL-1 protein A were used. The 
optimum antigen concentrations should cause higher difference in absorbance intensities 
between AuNPs incubated with positive serum and AuNPs incubated with negative serum. 
Higher difference, in other words, means a maximum interaction should take place between 
immobilized antigens and antibodies found in the positive serum; simultaneously, the 
negative sample should not cause any non-specific interaction with the AuNPs.  
Results showed also that higher affinity between immobilized antigens and anti-Borrelia 
antibody, which was observed as maximum aggregation of AuNPs incubated with positive 
serum, could be seen when phosphate buffer pH 7.4 was used. This is compatible with 
previously reported studies, which reported that maximum interaction of antibody-antigen 
interaction as well as protein A-antibody interaction could take place at pH 7.4.  
Results showed that increasing salt concentration hindered the interaction between 
immobilized proteins and anti-Borrelia antibodies when 20 nm AuNPs was used. 50 mM 
NaCl weakened the proteins interaction; this can be observed by the weak aggregation of 
AuNPs incubated with positive serum. Moreover, 100 mM NaCl totally prevented the 
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proteins interaction. Nevertheless, 30 nm AuNPs gave higher sensitive and more rapid test 
when 50 mM NaCl was added to the assay buffer.  
A convenient recognition of anti-Borrelia antibodies in sera samples was achievable using 
the three different sizes of AuNPs. UV-vis spectra showed the aggregation of nanoparticles 
incubated with positive sample. The aggregation is observed as a red shift in maximum 
absorbance and broadening in the absorption band. The reason for the aggregation as 
supposed should be due to the specific interaction of both antigens on the gold surface with 
the antibodies. This can be confirmed also when negative sample is tested and no visible 
change could be observed. 
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Summary 
The presented work describes the development of new ligand-binding assay platforms for 
rapid serological diagnosis. 3-D polyethylene sinter bodies and monodisperse gold 
nanoparticles have been successfully employed as protein carriers, providing sensitive, 
selective and rapid serological diagnosis. Detection of anti-Borrelia antibodies in human sera 
samples was taken as a model in our work. Antibodies recognition either by visible 
observation or by spectroscopic measurements was easily practicable. All developed assays 
could be performed in a short time, 5-30 min, providing a suitable colorimetric point of care 
test. The established assays offer simple, rapid and reliable tools of analysis with minimal 
cost, which can be easily transferred to other infectious diseases. In brief, thesis can be 
divided into three different parts; each part based on one new approach.  
In the first part, diagnosis of Lyme borreliosis has been carried out on chemically modified 
porous polyethylene sinter bodies. Photografting of 2-propenol on the polyethylene surface 
was performed as a first step. Active hydroxyl groups were introduced as a result of 
polyalcohol formation, which has been confirmed using different analysis techniques such as 
FTIR, SEM, and AFM. The hydroxyl groups were used for further immobilization and could 
be linked via 3-aminopropyltriethoxysilane to polysaccharides like mannan. Prone to mannan 
coupling, mannan was activated using N, N´-disuccinimidyl carbonate to allow smooth 
reaction with the primary amine groups of the silane layer. The high specific interaction 
between mannan polysaccharides and lectins was employed in a final preparation step; a 
recombinant fusion protein consisting of the mannan-binding domain of the lectin 
Concanavalin A (ConA) and a specific Borrelia surface antigen was immobilized by self-
organization on the mannan surface. This strategy is highly efficient and resulted in a defined 
orientation of the antigen part of the fusion protein. The binding of anti-Borrelia antibodies in 
human sera samples was detected by a color reaction in an ELISA-like manner in only 20 
min. Horseradish peroxidase (HRP) secondary labeled antibody was used as a label. The 
assay enabled a rapid and convenient differentiation between Borrelia-negative and -positive 
sera even in 1000-fold diluted samples and allows detection of Lyme borellioses in a rather 
early stage. This generic strategy can be easily transferred to other bacterial or viral antigen 
structures.  
In the second part, diagnosis of Lyme borreliosis has been carried out on porous 
polyethylene sinter bodies, which have been coated with VlsE antigen rather than mannan. 
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Sufficient amounts of VlsE antigen could be successfully immobilized on the surface using 
both hydrophobic adsorption and covalent immobilization. A special washing routine could 
be developed for the easy physical adsorption of the antigen. Covalent immobilization has 
been proposed as alternative to immobilize the antigen. Photografting of 2-propenol was 
conducted primarily to launch the covalent immobilization procedure. Activation of the 
produced hydroxyl groups enabled eventually an amine-coupling reaction to be pursued, 
resulting in binding of the antigen‘s N-terminus lysine amino groups to the activated 
intermediate on the surface. Detection of anti-Borrelia antibodies has been easily achieved 
using a ELISA like assay. Three labels were tested: i) a horseradish peroxidase (HRP) labeled 
secondary antibody, ii) nanoparticles based on Sudan IV, and iii) gold nanoparticles modified 
with protein A. HRP secondary labeled antibody provides the most sensitive test when 
integrated with 3-DPESB modified with hydrophobic adsorption; 1000 fold dilution of serum 
sample can be clearly detected in only 20 min. Gold nanoparticles modified with protein A 
could be employed in the ABICAP
TM 
technology as a very promising label. Detection of 
antibodies could be conducted in only 5 min; this advantageous approach could be 
established based on direct detection of AuNPs. Detection of metallic silver produced by 
catalytic activity of AuNPs was possible. Detection of metallic silver required longer time 
(12 min), but with improved sensitivity. Nanoparticles based on Sudan IV showed high 
background and were less favorable when real samples were tested.  
In the third part, the physical properties of AuNPs could be successfully employed to 
develop AuNPs able to detect target antibodies in human sera sample. AuNPs has been 
modified with two antigens, surface VlsE Borrelia antigen and protein A. The specific 
interaction of the two antigens with anti-Borrelia antibodies enabled the detection of the 
antibodies in human sera samples. Three different sizes (20, 30, and 40 nm) were tested; a 
convenient recognition of antibodies was achieved with all sizes using spectroscopy 
measurements. Moreover, 30 nm particles showed a very promising colorimetric detection; 
accumulation of nanoparticles could be visibly observed using naked eyes. The size of 
nanoparticles showed a crucial impact on the assay time; 3 h incubation was needed to obtain 
considerable results when 20 nm particles was used, while 30 min was needed with the 30 nm 
particles and only 1 min with the 40 nm particles. The proposed test can be performed only in 
one step with no additional washing steps. The test is promising, simple and suitable for 
point-of-care testing. Applying the proposed platform to other assays is suggested for rapid 
analysis.
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Zusammenfassung  
In der vorliegenden Arbeit wird die Verwendung von neuartigen Analytik-Plattformen 
beschrieben, mit denen Immunoassays für die schnelle serologische Diagnostik durchgeführt 
werden konnten. „3-D-Polyethylen-Sinterkörper‖ und monodisperse Goldnanopartikel  
wurden hierbei als Träger für proteinerge Erkennungsstrukturen erfolgreich eingesetzt. Es 
konnte dadurch eine sensitive, selektive und schnelle Diagnostik einer Borrelien-Infektion 
erreicht werden. Da der gewählte experimentell Ansatz generisch ist, kann er auch auf andere 
Krankheitserreger übertragen werden. Die Detektion der Antikörper erfolgte sowohl durch 
visuelle Auswertung als auch durch spektroskopische Messungen. Die entwickelten Assays 
können in einem Zeitraum von 5 – 30 Minuten durchgeführt werden; somit sind sie für Point 
of Care Tests geeignet. Die experimentellen Arbeiten sind in drei Bereiche Aufgeteilt: 
 
In dem ersten Teil wurde die Diagnostik der Lyme-Borreliose auf chemisch modifizierten 
porösen Polyethylensinterkörpern als Trägerstruktur durchgeführt. Es wurde 2-Propenol auf 
die Polyethylenoberfläche mit der Hilfe von UV-Strahlung immobilisiert. Aktive 
Hydroxylgruppen wurden durch Polymerisation eingeführt und durch verschiedene 
Analysetechniken wie FTIR, REM, AFM bestätigt. An diese konnten über 3-
Aminopropyltriethoxysilan Polysaccharide wie Mannan an die Oberfläche gebunden werden. 
Mannan wurde zuvor durch N,N´-Disuccinimidylcarbonat aktiviert, um die Bildung von 
Säureamidgruppen zu ermöglichen.  
Die hohe spezifische Wechselwirkung zwischen Mannan und Lektinen wie Concanavalin A 
(ConA) wurde in einer abschließenden Präparationphase ausgenutzt. Zur Verwendung kam 
hierbei ein rekombinantes Fusionsprotein, das sich aus dem Mannan-bindenden Domäne des 
ConA und einem spezifischen Borrelia-Oberflächenantigens, VlsE, zusammensetzt. Es wurde 
durch Selbstorganisation auf der Mannanoberfläche immobilisiert. Diese effiziente Strategie 
resultierte in einer definierten Orientierung des Antigen-Teils des Fusionsproteins. Die 
Bindung von anti-Borrelia Antikörpern aus humanen Seren wurde durch eine Farbreaktion in 
einem ELISA-ähnlichen Test binnen 20 Minuten bestimmt. Dabei wurden mit 
Meerrettichperoxidase (HRP) markierte, sekundäre Antikörper verwendet. Der Test 
ermöglicht sowohl eine schnelle und effiziente Unterscheidung zwischen Borrelien-negativen 
und –positiven Seren in bis  zu 1000-fach verdünnten Proben und erlaubt somit den 
Nachweis von Lyme-Borreliose in einem relativ frühen Stadium. Diese Methodik kann leicht 
auf andere bakterielle oder virale Antigenstrukturen übertragen werden.  
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In dem zweiten Teil dieser Studie wurde der erhaltene Assay optimiert und unterschiedle 
Immobilisierungsstrategie und Detektionsmethoden vergleichend untersucht. Die 
Immobilisierung des Antigens auf der Polyethylenoberfläche konnte sowohl durch 
hydrophobe Adsorption sowie kovalente Bindung des Antigens auf der Oberfläche 
erfolgreich durchgeführt werden. Zur einfachen physikalischen Adsorption des Antigens 
konnte eine spezielle Wasch-Routine entwickelt werden. Die Oberflächenmodifikation des 
Polyethylens erfolgte durch UV-induzierte Polymerisation von 2-Propenol. Die erzeugten 
Hydroxylgruppen wurden zuerst zu Carbamaten umgesetzt. Hierzu wurden Amin-
Kupplungsreaktion durchgeführt; die Proteine wurden über die freie Aminogruppe des N-
Terminus oder des Lysins an diese gebunden. Der Nachweis von anti-Borrelia Antikörpern in 
den Serumproben wurde durch einen kolorimetrischen Assay ermöglicht. Drei Label wurden 
getestet: i) ein Meerrettichperoxidase (HRP) markierte sekundärer Antikörper ii) 
Nanopartikel auf Basis von Sudan IV, und iii) Gold-Nanopartikel, die mit Protein A 
modifiziert wurden. HRP markierte sekundärer Antikörper lieferten den empfindlichsten 
Test; ein 1000-fache Verdünnung der Serumproben konnte deutlich in nur 20 min detektiert 
werden. Die Protein A modifizierten Gold-Nanopartikel stellen eine vielversprechende 
Alternative dar. Der Nachweis von  Antikörpern konnte in sehr kurzer Zeit erreicht werden (5 
min).  Diese Steigerung der Nachweisgeschwindigkeit konnte durch die direkte Detektion 
von Goldnanopartikeln erreicht werden. Als weiteres Label konnte Silber verwendet werden, 
um die Sensitivität des Tests zu erhöhen. Silber-Ionen wurden reduziert, um elementares 
Silber zu erhalten. Die Detektion benötigt eine längere Zeit (12 min), jedoch mit verbesserter 
Sensitivität. Nanopartikeln auf Basis von Sudan IV zeigten einen hohen Hintergrund und 
waren nur mäßig für Seren-Proben geeignet. Das entwickelte Verfahren bietet eine einfache, 
schnelle und zuverlässige Analysemethode mit minimalen Kosten und kann leicht an andere 
Infektionen angepasst werden.  
In dem dritten Teil der Arbeit wurden  die besonderen spektroskopischen Eigenschaften von 
Gold-Nanopartikeln ausgenutzt, um anti-Borrelia Antikörper in menschlichen Seren 
nachzuweisen. Gold-Nanopartikeln wurden mit zwei Proteinen modifiziert; VlsE Borrelia-
Antigen und Protein A. Die spezifische Wechselwirkung der beiden Proteine mit anti-
Borrelia Antikörpern in menschlichen Serumproben führte zu einer Aggregation der 
Goldnanopartikel. Goldnanopartikel wurden in drei verschieden Größen (20, 30 und 40 nm) 
getestet; eine geeignete Identifikation von Antikörpern wurde bei allen Größen mittels 
spektroskopischer Messungen erreicht. Zusätzlich zeigten die 30 nm Partikel eine 
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vielversprechende kolorimetrische auswertbare Reaktion; Die Akkumulation von 
Nanopartikel konnte mit dem bloßen Auge beobachtet werden. Die Größe der verwendeten 
Nanopartikel hatte einen entscheidenden Einfluss auf die Dauer der Testverfahren. Es wurden 
3 h Inkubationszeit benötigt um auswertbare Ergebnisse bei den 20 nm Partikeln zu erhalten, 
30 min bei den 30 nm Partikeln und lediglich 1 min bei den 40 nm Partikeln. Der 
vorgeschlagen Test kann auch in nur einem Schritt ohne weitere Waschschritte durchgeführt 
werden. Dieser Ansatz erscheint vielversprechend, einfach und somit gut geeignet für Point 
of Care Tests. Die Verwendung dieser Plattform für andere Tests auf verschiedenste Viren 
und Bakterien (bzw. dagegen gerichtete Antikörper) kann in Zukunft zu schnellen 
Ergebnissen führen, ohne dass eine Laborausrüstung erforderlich ist. 
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